NOVEL HERBICIDES
The present invention relates to novel, herbicidally active phenyl-alkynes, to processes for their preparation, to compositions comprising those compounds, and to their use in controlling weeds, especially in crops of useful plants, or in inhibiting plant growth. .
Phenyl-alkynes having herbicidal action are described, for example, in JP-A-11 147 866, WO 01/55066 and WO 02/28182.
Novel phenyl-alkynes that have herbicidal and growth-inhibiting properties have now been found.
The present invention accordingly relates to compounds of formula I
n is O, 1, 2, 3 or 4;
R is hydrogen, CORι
2, -S(O)
qC
rC
galkyl, Cι-C
8alkyl, C
3-C
8alkenyl, C
3-C
8alkynyl or C
3-C
6cycloalkyl; or Ci-Csalkyl, C
3-C
8alkenyl or C
3-C
8alkynyl each substituted from one to five times by halogen and/or once, twice or three times by substituents selected from Cι-C
4alkoxy, -CN, -S(O)
qCι-C
8alkyl and phenyl, wherein the phenyl ring may in turn be substituted from one to five times by substituents selected from halogen and Cj- alkyl and/or once, twice or three times by substituents selected from Cι-C
4haloalkyl, C C
4alkoxy, -CN, -NO
2 and -SCO^d- alkyl, or
R is C3-C6cycloalkyl substituted from one to five times by substituents selected from halogen and Cι-C alkyl and/or once, twice or three times by substituents selected from d-C4alkoxy, -CN and phenyl, wherein the phenyl ring may in turn be substituted from one to five times by substituents selected from halogen and Cι-C4alkyl and/or once, twice or three times by substituents selected from Cι-C alkoxy, -CN, -N02 and -S(0)qd-C8alkyl, or R is phenyl, wherein the phenyl ring may be substituted from one to five times by substituents selected from halogen and methyl and/or once, twice or three times by substituents selected from -CF3, -OCH3, -CN, -NO and -S(0)qCi-C4alkyl; or, when n is 0, 1, 2 or 3,
R forms a Cι-C6alkylene or C2-C6alkenylene bridge attached to the phenyl ring in the 3- position, which bridge may be interrupted by an oxygen atom and/or may be substituted by Ci -C6alkyl, an oxygen-oxygen bond being excluded and the total number of ring atoms being at least 5 and at most 9; each Ri independently of any other(s) may be halogen, -CN, -SCN, -SF5, -N02, -NRsRό, -C02R7, -CONR8R9, -C( ιo)=NORιι, -COR12, -OR,3, -SRι4, -SOR15, -S02Rι6, -OSO2Rι7, Cι-C8alkyl, C2-C8alkenyl, C2-C8alkynyl or C3-C6cycloalkyl; or is Cι-C8alkyl, C2-C8alkenyl or C2-C8alkynyl substituted from one to five times by halogen and/or once, twice or three times by substituents selected from -CN, -NO2, -NR18R19, -CO2R20, -CONR2ιR22, -COR23, -C(R2 )=NOR25, -C(S)NR26R27, -C(C1-C4alkylthio)=NR28, -OR29, -SR30, -SOR31, -SO2R32 and C3-C6cycloalkyl; and/or each Ri independently of any other(s) may be C3-C6cycloalkyl substituted from one to five times by halogen and/or once, twice or three times by substituents selected from -CN, -NO2, -NR,8Ri9, -CO2R20, -CONR2,R22, -COR23, -C(R24)=NOR25, -C(S)NR26R27, -C(CrC4alkylthio)=NR28, -OR29, -SR30, -SOR31, -SO2R32 and C3-C6cycloalkyl; and/or
each Ri independently of any other(s) may be phenyl which may in turn be substituted from one to five times by substituents selected from halogen and Cι-C4alkyl and/or once, twice or three times by substituents selected from Cι-C4haloalkyl, d-C4alkoxy, -CN, -N02, Cι-C4alkylthio, C C4alkylsulfmyl and d-C4alkylsulfonyl; or, when Q is a group Qi, Q2, Q3, Q4, Q5 or Q7, two adjacent Rj radicals may together form a Cι-C alkylene or C2-C7alkenylene bridge which may be interrupted by from 1 to 3 hetero atoms selected from oxygen, nitrogen and sulfur and/or may be substituted from one to five times by substituents selected from halogen and Cι-C6alkyl and/or once, twice or three times by Cι-C6alkoxy, the total number of ring atoms being at least 5 and at most 9; R5 is hydrogen or Cι-C8alkyl;
R6 is hydrogen, Cι-C8alkyl, C3-C8alkenyl, C3-C8alkynyl, phenyl or benzyl, wherem phenyl and benzyl may in turn be substituted from one to five times by substituents selected from halogen and Cι-C4alkyl and/or once, twice or three times by substituents selected from Cι-C4haloalkyl, Cι-C alkoxy, -CN, -N02, Cι-C alkylthio, Cι-C4alkylsulfmyl and Cι-C4alkylsulfonyl, or
R6 is Cι-C8alkylcarbonyl, wherein the Cι-C8alkyl chain may in turn be substituted by substituents selected from halogen, -CN, Cι-C6alkylamino, di(Cι-C6alkyl)amino and Cι-C4alkoxy; or R5 and Rό together are a C2-C alkylene chain which may be interrupted by an oxygen or sulfur atom;
R7 is hydrogen, Cι-C8alkyl, C3-C8alkenyl or C3-C8alkynyl, or Cι-C8alkyl, C3-C8alkenyl or d-Csalkynyl each substituted from one to five times by halogen and/or once, twice or three times by substituents selected from Cι-C4alkoxy and phenyl, wherein phenyl may in turn be substituted from one to five times by substituents selected from halogen and Cι-C4alkyl and/or once, twice or three times by substituents selected from
Ci -C4haloalkyl, C C4alkoxy, -CN, -NO , Cι-C4alkylthio, Cι-C4alkylsulfmyl and
C 1 -C4alkylsulfonyl;
R8 and R9 are each independently of the other hydrogen or C]-C8alkyl, or C -C8alkyl substituted once, twice or three times by substituents selected from -COOH, Cι-C8alkoxycarbonyl and -CN, or
R8 and R9 are each independently of the other C3-C8alkenyl, C3-C8alkynyl, phenyl or benzyl, wherein phenyl and benzyl may in turn be substituted from one to five times by substituents selected from halogen and Cι-C4alkyl and/or once, twice or three times by
substituents selected from d-C halo alkyl, Cι-C alkoxy, -CN, -NO2, Cι-C alkylthio, Cι-C alkylsulfmyl and Cι-C4alkylsulfonyl; or R8 and R together are C -C5alkylene;
Rio is hydrogen, Cι-C4alkyl, Cι-C4haloalkyl or C3-C6cycloalkyl; Rii is hydrogen, d-Cgalkyl, C3-C8alkenyl, C3-C8alkynyl, Cι-C4haloalkyl or C3-C6haloalkenyl;
R12 is hydrogen, d-C alkyl, Cι-C4haloalkyl or C3-C6cycloalkyl; Rι3 is hydrogen, Cι-C8alkyl, C3-C8alkenyl or C3-C8alkynyl; or Ri3 is phenyl or phenyl-Cι-C6alkyl, wherein the phenyl ring may in turn be substituted from one to five times by substituents selected from halogen and Cι-C4alkyl and/or once, twice or three times by substituents selected from Cι-C4haloalkyl, Cι-C4alkoxy, -CN, -NO2, Ci-Cgalkylthio, Cι-C8alkylsulfinyl and d-C8 alkylsulfonyl; or Rι3 is Cι-C8alkyl substituted from one to five times by halogen and/or once, twice or three times by substituents selected from -CN, Cι-C6alkylamino, di(d-C6alkyl)amino and Cι-C alkoxy, or
R]3 is Cι-C8alkylcarbonyl, wherein the Cι-C8alkyl chain may in turn be substituted by substituents selected from halogen, -CN, Cι-C6alkylamino, di(Cι-C6alkyl)amino and
Cι-C alkoxy;
R]4 is hydrogen, Cι-C8alkyl, C3-C8alkenyl or C3-C8alkynyl, or Cι-C8alkyl substituted from one to five times by halogen and/or once, twice or three times by substituents selected from -CN and Cι-C4alkoxy;
R15, Ri6 and Rι7 are each independently of the others Cι-C8alkyl, C3-C8alkenyl or d-Qalkynyl, or Cι-C8alkyl substituted from one to five times by halogen and/or once, twice or three times by substituents selected from -CN and Cι-C4alkoxy; Rig is hydrogen or Cι-C8alkyl;
Rι9 is hydrogen, d-C8alkyl, C3-C8alkenyl, C3-C8alkynyl, phenyl or benzyl, wherein phenyl and benzyl may in turn be substituted from one to five times by substituents selected from halogen and Cι-C4alkyl and/or once, twice or three times by substituents selected from Cι-C4haloalkyl, Cι-C alkoxy, -CN, -NO2, d-C alkylthio, Cι~C4alkylsulfinyl and C]-C4alkylsulfonyl; or
Ris and Rι9 together are a C -C5alkylene chain which may be interrupted by an oxygen or sulfur atom;
R20 is hydrogen, Cι-C8alkyl, C3-C8alkenyl, C3-C8alkynyl, phenyl or benzyl, wherein phenyl and benzyl may in turn be substituted from one to five times by substituents selected from halogen and Cι-C4alkyl and/or once, twice or three times by substituents selected from Cι-C4haloalkyl, Cι-C4alkoxy, -CN, -NO2, Cι-C alkylthio, Cι-C4alkylsulfinyl and C]-C alkylsulfonyl; R2ι is hydrogen or Cι-C8alkyl;
R22 is hydrogen or Cι-C8alkyl, or Cι-C8alkyl substituted once, twice or three times by substituents selected from -COOH, Cι-C8alkoxycarbonyl and -CN, or R22 is C3-C8alkenyl, C3-C8alkynyl, phenyl or benzyl, wherein phenyl and benzyl may in turn be substituted from one to five times by substituents selected from halogen and Cι-C4alkyl and/or once, twice or three times by substituents selected from Cι-C4haloalkyl, Cι-C4alkoxy, -CN, -NO2, d-C4alkylthio, C C4alkylsulfinyl and Cι-C alkylsulfonyl; or R21 and R22 together are C2-C5alkylene; R23 is hydrogen, Cι-C4alkyl, Cι-C4haloalkyl or C3-C6cycloalkyl; R24 is hydrogen, Cι-C4alkyl, d-C4haloalkyl or C3-C6cycloalkyl; R25 is hydrogen, Cι-C8alkyl, C3-C8alkenyl, C3-C8alkynyl, Cι-C4haloalkyl or C3-C6haloalkenyl; R26 is hydrogen or Cι-C8alkyl; R27 is hydrogen or d-C8alkyl, or Cj-C8alkyl substituted once, twice or three times by substituents selected from -COOH, Cι-C8alkoxycarbonyl and -CN, or R27 is C3-C8alkenyl, C -C8alkynyl, phenyl or benzyl, wherein phenyl and benzyl may in turn be substituted from one to five times by substituents selected from halogen and Cι-C4alkyl and/or once, twice or three times by substituents selected from Cι-C4haloalkyl, Cι-C4alkoxy, -CN, -NO2, Cι-C4alkylthio, Cι-C alkylsulfinyl and d-C4alkylsulfonyl; or R26 and R27 together are C2-C5alkylene; R28 is hydrogen or d-Csalkyl; R29 and R30 are each independently of the other hydrogen, d-C8alkyl, C -C8alkenyl or C3-Csalkynyl, or C]-C8alkyl substituted from one to five times by halogen and/or once, twice or three times by substituents selected from -CN and Cι-C4alkoxy;
R3ι and R32 are each independently of the other d-Csalkyl, C3-C8alkenyl or C3-C8alkynyl, or Cι-C8alkyl substituted from one to five times by halogen and/or once, twice or three times by substituents selected from -CN and Cι-C alkoxy; m is 0, 1, 2, 3, 4 or 5; each R2 independently of any other(s) may be halogen, -CN, -SCN, -OCN, -N3, -SF5, -NO2, -NR33R34, -C02R35, -CONR36R 7, -C(R38)=NOR39, -COR40, -OR41, -SR42, -SOR^, -SO2R44, -OSO2R 5, -N([CO]pR46)COR47, -N(OR54)COR55, -N(R56)SO2R57, -N(SO2R58)SO2R59, -N=C(OR60)R6ι, -CR62(OR63)OR64, -OC(O)NR65R66, -SC(O)NR67R68, -OC(S)NR69R70 or -N-phthalimide; and/or R2 may be a 5- to 7-membered heterocyclic ring system which may be aromatic or partially or fully saturated and may contain from 1 to 4 hetero atoms selected from nitrogen, oxygen and sulfur, which heterocyclic ring system may in turn be substituted from one to five times by substituents selected from halogen and Cι-C alkyl and/or once, twice or three times by substituents selected from Cι-C4haloalkyl, hydroxy-Cι-C4alkyl, d-C4alkoxy, Cι-C4alkoxy-C1-C4alkyl, -CN, -NO2, Cι-C6alkylthio, d-C6alkylsulfmyl and Cι-C6alkylsulfonyl; R33 is hydrogen or Cι-C8alkyl; and
R34 is hydrogen, Cι-C8alkyl, CrQalkenyl, C3-C8alkynyl, phenyl or benzyl, wherein phenyl and benzyl may in turn be substituted from one to five times by substituents selected from halogen and Cι-C4alkyl and/or once, twice or three times by substituents selected from Cι-C4haloalkyl, Cι-C4alkoxy, -CN, -NO2, Cι-C4alkylthio, Cι-C4alkylsulfinyl and Cι-C4alkylsulfonyl, or
R34 is Ci-dalkylcarbonyl unsubstituted or substituted by substituents selected from halogen, -CN, Cι-C6alkylamino, di(Cι-C6alkyl)amino and Cι-C4alkoxy; or R33 and R3 together are a d-dalkylene chain which may be interrupted by an oxygen or sulfur atom;
R35 is hydrogen, Cι-C8alkyl, C3-C8alkenyl or C3-C8alkynyl, or Cι-C8alkyl, C3-C8alkenyl or C3-C8alkynyl each substituted from one to five times by halogen and/or once, twice or • three times by substituents selected from Cι-C4alkoxy and phenyl, wherein phenyl may in turn be substituted from one to five times by substituents selected from halogen and Cι-C4alkyl and/or once, twice or three times by substituents selected from C,-C4haloalkyl, Cι-C4alkoxy, -CN, -NO2, Cι-C4alkylthio, d-C4alkylsulfmyl and Cι-C4alkylsulfonyl;
R36 is hydrogen or Cι-C8alkyl;
R37 is hydrogen or Cι-C8alkyl, or Cι-C8alkyl substituted once, twice or three times by substituents selected from -COOH, Ci-Csalkoxycarbonyl and -CN, or
R37 is C3-C8alkenyl, C3-Csalkynyl, phenyl or benzyl, wherein phenyl and benzyl may in turn be substituted from one to five times by substituents selected from halogen and
Cι-C alkyl and/or once, twice or three times by substituents selected from
Cι-C4haloalkyl, Cι-C4alkoxy, -CN, -NO2, Cι-C4alkylthio, Cι-C4alkylsulfmyl and
Cι-C4alkylsulfonyl; or
R36 and R37 together are Crdalkylene; R38 is hydrogen, Cι-C4alkyl, C]-C4haloalkyl or C3-C6cycloalkyl;
R39 is hydrogen, Cι-C8alkyl, C3-C8alkenyl, C3-C8alkynyl, Cι-C haloalkyl or
C3-C6haloalkenyl;
R40 is hydrogen, Cι-C4alkyl, C C4haloalkyl, Cι-C8alkylthio, -C(O)-C(0)OCι-C4alkyl or
C3-C6cycloalkyl; R4ι is hydrogen, Cι-C8alkyl, C3-C8alkenyl, C3-C8alkynyl, Cι-C6alkoxy-Cι-C6alkyl,
Cι-C8alkylcarbonyl, Cι-C8haloalkylcarbonyl, Cι-C8alkoxycarbonyl,
C3-C8alkenyloxycarbonyl, Cι-C6alkoxy-Cι-C6alkoxycarbonyl, Cι-C6alkylthio-
Cι-C6alkyl, Cι-C6alkylsulfinyl-Cι-C6alkyl or Cι-C6alkylsulfonyl-Cι-C6alkyl; or
R41 is phenyl or phenyl-Cι-C6alkyl, wherein the phenyl ring may in turn be substituted from one to five times by substituents selected from halogen and Cι-C4alkyl and/or once, twice or three times by substituents selected from C]-C4haloalkyl, Cι-C4alkoxy, -CN,
-NO2 and -S(0)2Ci-C8alkyl, or
R41 is Cι-C8alkyl substituted from one to five times by halogen and/or once, twice or three times by substituents selected from -COOH, Cι-C8alkoxycarbonyl, Cι-C6alkylamino, di(Cι-C6alkyl)amino and -CN;
R 2 is hydrogen, Cι-C8alkyl, C3-C8alkenyl or C3-C8alkynyl, or Cι-C8alkyl substituted from one to five times by halogen and/or once, twice or three times by substituents selected from -CN and Cι-C4alkoxy;
R4 and R44 are each independently of the other Cι-C8alkyl, C3-C8alkenyl or C3-C8alkynyl, or Cι-C8alkyl substituted from one to five times by halogen and/or once, twice or three times by substituents selected from -CN and Cι-C4alkoxy;
R45 is Cι-C8alkyl, C3-C8alkenyl or C3-C8alkynyl, or Cι-C8alkyl substituted from one to five times by halogen and/or once, twice or three times by substituents selected from -CN and d-C alkoxy, or
R45 is phenyl, wherein the phenyl ring may be substituted from one to five times by substituents selected from halogen and Cι-C4alkyl and/or once, twice or three times by substituents selected from Cι-C4haloalkyl, Cι-C alkoxy, -CN, NO2, d-Qalkylthio, d-C8alkylsulfinyl and Cι-C8alkylsulfonyl;
R46 is hydrogen, Ci-Csalkyl, C3-C8alkenyl, C3-C8alkynyl or Cι-C4haloalkyl;
R 7 is hydrogen, Cι-C8alkyl, Cι-C4alkoxy, C3-C8alkenyl or C3-C8alkynyl, or Cι-C8alkyl substituted from one to five times by halogen and/or once, twice or three times by substituents selected from -CN, Cι-C4alkoxy, Cι-C8alkoxycarbonyl, -NH2,
Cι-C4alkylamino, di(CrC4alkyl)amino, -NR48COR49, -NR5oSO2R5ι and -NR52CO2R53, or
R47 is phenyl or benzyl, wherein phenyl and benzyl may in turn be substituted from one to five times by substituents selected from halogen and Cι-C4alkyl and/or once, twice or three times by substituents selected from Cι-C4haloalkyl, C]-C4alkoxy, -CN, -NO2,
Cι-C4alkylthio, Cι-C4alkylsulfinyl and Cι-C4alkylsulfonyl; p is 0 or 1 ;
R48, R49, R5o, R51, R52 and R53 are each independently of the others hydrogen, Cι-C8alkyl, phenyl, benzyl or naphthyl, wherein the three last-mentioned aromatic radicals may in turn be substituted from one to five times by substituents selected from halogen and
Ci-Csalkyl and/or once, twice or three times by substituents selected from
Cι-C4haloalkyl, Cι-C4alkoxy, Cι-C alkylamino, di(Cι-C alkyl)amino, -NH2, -CN, -N02,
Cι-C4alkylthio, Cι-C4alkylsulfmyl and Cι-C4alkylsulfonyl;
R54 and R55 are each independently of the other hydrogen, Cι-C8alkyl or phenyl which may in turn be substituted from one to five times by substituents selected from halogen and Cι-C4alkyl and/or once, twice or three times by substituents selected from
Cι-C4haloalkyl, Cι-C4alkoxy, -CN, -NO2, Cι-C8alkylthio, C C8alkylsulfmyl and
C 1 -C8 alkylsulfonyl ;
R56 is hydrogen, Cι-C8alkyl, Cι-C4haloalkyl, Cι-C alkoxy, C3-C8alkenyl, C3-C8alkynyl or benzyl, wherein benzyl may in turn be substituted from one to five times by substituents selected from halogen and Cι-C4alkyl and/or once, twice or three times by substituents selected from Cι-C4haloalkyl, Cι-C4alkoxy, -CN, -NO2, Cι-C8alkylthio,
Ci-Csalkylsulfmyl and Cι-C8alkylsulfonyl;
R57 is Cι-C8alkyl, Cι-C haloalkyl, phenyl, benzyl or naphthyl, wherein the latter three aromatic rings may be substituted from one to five times by substituents selected from halogen and Cι-C4alkyl and/or once, twice or three times by substituents selected from Cι-C4haloalkyl, Cι-C alkoxy, d-C4alkylamino, di(d-C alkyl)amino, -NH2, -CN, -N02, Cι-C4alkylthio, Cι-C4alkylsulfinyl and d-C4alkylsulfonyl;
R58 and R59 are each independently of the other Cι-C8alkyl, C3-C8alkenyl, C3-C8alkynyl, phenyl, benzyl or naphthyl, wherein the latter three aromatic rings may be substituted from one to five times by substituents selected from halogen and Cι-C4alkyl and/or once, twice or three times by substituents selected from Cι-C4haloalkyl, Cι-C4alkoxy, Cι-C4alkylamino, di(Cι-C alkyl)amino, -NH2, -CN, -N02, Cι-C4alkylthio, Cι-C4alkylsulfinyl and Cι-C4alkylsulfonyl;
R60 and R6ι are each independently of the other hydrogen or Cι-C6alkyl; R62, R<53 and 54 are each independently of the others hydrogen or Cι-C8alkyl, or R63 and R64 together form a C2-C5alkylene bridge; R65, Rό6, R67, Res, R69 and R70 are each independently of the others hydrogen or Cι-C8alkyl, or
R s and R
6, or R
67 and R^s, or R
δ9 and R
70 together in each case form a C
2-C
5alkylene bridge; and/or each R
2 independently of any other(s) may be Cι-C
8alkyl, or Cι-C
8alkyl substituted from one to five times by halogen and/or once, twice or three times by substituents selected from -CN, -N
3, -SCN, -NO
2, -NR
7ιR
72, -CO
2R
73, -CONR
74R
75, -COR
76, -C(R
77)=NOR
78, -C(S)NR
79R
80, -C(Cι-C
4alkylthio)=NR
8ι, -OR
82, -SR
83, -SOR
84, -SO
2R
85, -O(S0
2)R
86, -N(R
87)CO
2R
88, -N(R
89)COR
90, -S
+(R
9ι)
2, -N
+(R
92)
3, -Si(R
93)
3 and C
3-C
6cycloalkyl; and/or each R
2 independently of any other(s) may be Cι-C
8alkyl substituted by a 5- to 7- membered heterocyclic ring system which may be aromatic or partially or fully saturated and may contain from 1 to 4 hetero atoms selected from nitrogen, oxygen and sulfur, wherein that heterocyclic ring system may in turn be substituted from one to five times by substituents selected from halogen and Cι-C
4alkyl and/or once, twice or three times by substituents selected from Cι-C
4haloalkyl, hydroxy-Cι-C
4alkyl, Cι-C
4alkoxy, Cι-C
4alkoxy-Cι-C
4alkyl, -CN, -NO
2, Cι-C
6alkylthio, Cι-C
6alkylsulfmyl and Cι-C
6alkylsulfonyl; and/or
each R
2 independently of any other(s) may be C
2-C
8alkenyl, or C
2-C
8alkenyl substituted from one to five times by halogen and/or once, twice or three times by substituents selected from -CN, -N0
2, -C0
2R
94, -CONR
95R
96, -COR
97, -C(R
98)=NOR
99, -C(S) RιooRιoι,
-OR103, -Si(Rι
04)
3 and C
3-C
6cycloalkyl; and/or each R
2 independently of any other(s) may be C
2-C
8alkynyl, or C
2-C
8alkynyl substituted from one to five times by halogen and/or once, twice or three times by substituents selected from -CN, -CO
2Rι
05, -CONR,
06Rιo7, -CORι
08, -C(Rιo9)=NORn
0, -C(S)NRnιRn2, -C(d-C
4alkylthio)=NRπ
3, -ORn
4, -Si(R
π5)
3 and C
3-C
6cycloalkyl; and/or each R
2 independently of any other(s) may be d-dcycloalkyl, or C
3-C
6cycloalkyl substituted from one to five times by halogen and/or once, twice or three times by substituents selected from -CN, -CO
2Rn
6, -CONRn
7Rn
8, -CORn
9, -C(Rι
20)=NORι
2ι, -C(S)NRi2 Ri23 and -C(d-C
4alkylthio)==NRι
2 ; and/or two adjacent R
2 radicals together may form a Cι-C
7alkylene bridge which may be interrupted by from 1 to 3 hetero atoms selected from oxygen, nitrogen and sulfur and/or may be substituted from one to five times by substituents selected from halogen and Cι-C
6alkyl and/or once, twice or three times by Cι-C
6alkoxy, the total number of ring atoms being at least 5 and at most 9; and/or two adjacent R
2 radicals together may form a C
2-C
7alkenylene bridge which may be interrupted by from 1 to 3 hetero atoms selected from oxygen, nitrogen and sulfur and/or may be substituted from one to five times by substituents selected from halogen and Cι-C
6alkyl and or once, twice or three times by Cι-C
6alkoxy, the total number of ring atoms being at least 5 and at most 9; R
71 is hydrogen or Cι-C
8alkyl;
R72 is hydrogen, Cι-C8alkyl, d-Qalkenylj d-dalkynyl, phenyl or benzyl, wherein phenyl and benzyl may in turn be substituted from one to five times by substituents selected from halogen and C]-C4alkyl and/or once, twice or three times by substituents selected from Cι-C4haloalkyl, Cι-C alkoxy, -CN, -NO2, Cι-C4alkylthio, Cι-C4alkylsulfinyl and Cι-C4alkylsulfonyl; or
R7ι and R72 together are a C2-C5alkylene chain which may be interrupted by an oxygen or sulfur atom;
R73 is hydrogen, Cι-C8alkyl, C3-C8alkenyl or C3-C8alkynyl, or Cι-C8alkyl, C3-C8alkenyl or d-Qalkynyl substituted from one to five times by halogen and/or once, twice or three times by substituents selected from Cι-C4alkoxy and phenyl, wherein phenyl may in turn be substituted from one to five times by substituents selected from halogen and C]-C4alkyl and/or once, twice or three times by substituents selected from Ci-dhaloalkyl, Cι-C4alkoxy, -CN, -N02, d-C4alkylthio, Cι-C4alkylsulfmyl and Ci -C4alkylsulfonyl;
R74 is hydrogen or d-C8alkyl;
R75 is hydrogen, Cι-C8alkyl or d-dcycloalkyl, or Cι-C8alkyl substituted once, twice or three times by substituents selected from -COOH, Cι-C8alkoxycarbonyl, Cι-C6alkoxy and -CN; or
R75 is d-dalkenyl, C3-C8alkynyl, phenyl or benzyl, wherein phenyl and benzyl may in turn be substituted from one to five times by substituents selected from halogen and
Cι-C4alkyl and/or once, twice or three times by substituents selected from Cι-C4haloalkyl, Cι-C4alkoxy, -CN, -N02, d-C4alkylthio, Cι-C alkylsulfmyl and
Cι-C alkylsulfonyl; or
R74 and R75 together are a d-dalkylene chain which may be interrupted by an oxygen or sulfur atom;
R76 is hydrogen, Cι-C4alkyl, Cι-C4haloalkyl or C3-C6cycloalkyl; R77 is hydrogen, Cι-C4alkyl, Cι-C4haloalkyl or C3-C6cycloalkyl;
R78 is hydrogen, Cι-C8alkyl, C3-C8alkenyl, C3-C8alkynyl, Cι-C4haloalkyl or
C3-C6haloalkenyl; and
R79 is hydrogen or d-C8alkyl;
R80 is hydrogen or Cι-C8alkyl, or Cι-C8alkyl substituted once, twice or three times by substituents selected from -COOH, Cι-C8alkoxycarbonyl and -CN; or
R8o is C3-C8alkenyl, C3-C8alkynyl, phenyl or benzyl, wherein phenyl and benzyl may in turn be substituted from one to five times by substituents selected from halogen and
Cι-C4alkyl and/or once, twice or three times by substituents selected from
Cι-C4haloalkyl, d-C4alkoxy, -CN, -NO2, Cι-C4alkylthio, Cι-C4alkylsulfmyl and Cι-C4alkylsulfonyl; or
R 9 and R80 together are C2-C5alkylene;
R8ι is hydrogen or Cι-C8alkyl;
R82 is -Si(Cι-C6alkyl)3, Cι-C8alkyl, C3-C8alkenyl or C3-C8alkynyl, or Cι-C8alkyl which is substituted from one to five times by halogen and/or once, twice or three times by substituents selected from -CN, -NH2, Cι-C6alkylamino, di(Cι-C6alkyl)amino and C]-C4alkoxy; R83 is hydrogen, Cι-C8alkyl, C3-C8alkenyl, C3-C8alkynyl, or Ci-Csalkyl which is substituted from one to five times by halogen and or once, twice or three times by substituents selected from -CN, -NH2, Cι-C6alkylamino, di(Cι-C6alkyl)aminό and d-C4alkoxy; Rs , R85 and R86 are each independently of the others Cι-C8alkyl, C3-Csalkenyl or C -C8alkynyl, or Cι-C8alkyl which is substituted from one to five times by halogen and/or once, twice or three times by substituents selected from -CN and Cι-C4alkoxy; R87 and R89 are each independently of the other hydrogen, Cι-C8alkyl or Cι-C8alkoxy; R88 is C,-C8alkyl; R90 is hydrogen or Cι-C8alkyl; R9ι is Cι-C4alkyl;
R92 and R93 are each independently of the other Cι-C6alkyl;
R94 is hydrogen, or Cι-C8alkyl, C3-C8alkenyl or C3-C8alkynyl each of which may be substituted from one to five times by halogen and/or once, twice or three times by substituents selected from Cι-C4alkoxy and phenyl, wherein phenyl may in turn be substituted from one to five times by substituents selected from halogen and Cι-C4alkyl and/or once, twice or three times by substituents selected from Cι-C4haloalkyl, Cι-C4alkoxy, -CN, -NO2, Cι-C4alkylthio, Cι-C4alkylsulfmyl and Cι-C4alkylsulfonyl; R95 is hydrogen or Cι-C8alkyl; R96 is hydrogen or Cι-C8alkyl, or Cι-C8alkyl substituted once, twice or three times by substituents selected from -COOH, Cι-C8alkoxycarbonyl and -CN; or
R96 is C3-C8alkenyl, C3-C8alkynyl, phenyl or benzyl, wherein phenyl and benzyl may in turn be substituted from one to five times by substituents selected from halogen and Cι-C4alkyl and/or once, twice or three times by substituents selected from Cι-C4haloalkyl, Cι-C4alkoxy, -CN, -NO2, Cι-C4alkylthio, Cι-C4alkylsulfinyl and Cι-C4alkylsulfonyl; or
R95 and R96 together are d-dalkylene;
R97 and R98 are each independently of the other hydrogen, Cι-C4alkyl, d-C4haloalkyl or
C3-C6cycloalkyl;
R99 is hydrogen, Cι-C8alkyl, C3-C8alkenyl, C3-C8alkynyl, C C4haloalkyl or C3-C6haloalkenyl; Rioo is hydrogen or Cι-C8alkyl; Rioi is hydrogen or d-C8alkyl, or Cι-C8alkyl substituted once, twice or three times by substituents selected from -COOH, Cι-C8alkoxycarbonyl and -CN; or Rioi is C3-C8alkenyl, C3-C8alkynyl, phenyl or benzyl, wherein phenyl and benzyl may in turn be substituted from one to five times by substituents selected from halogen and Cι-C4alkyl and/or once, twice or three times by substituents selected from d-C4haloalkyl, Cι-C alkoxy, -CN, -NO2, Cι-C4alkylthio, Cι-C4alkylsulfmyl and Ci-Qalkylsulfonyl; or Rioo and R10ι together are d-dalkylene;
R102 is hydrogen or d-C8alkyl;
R103 is hydrogen, C C8alkyl, -Si(d-C6alkyl)3, C3-C8alkenyl or C3-C8alkynyl;
Rιo4 is Cι-C6alkyl; R105 is hydrogen, or Ci-Qalkyl, C3-C8alkenyl or C3-C8alkynyl each of which may be substituted from one to five times by halogen and/or once, twice or three times by substituents selected from Cι-C4alkoxy and phenyl, wherein phenyl may in turn be substituted from one to five times by substituents selected from halogen and d-C4alkyl and/or once, twice or three times by substituents selected from Cι-C4haloalkyl, d-C4alkoxy, -CN, -NO2, CrC4alkylthio, Cι-C4alkylsulfinyl and Ci-Qalkylsulfonyl; R106 is hydrogen or d-C8alkyl;
Ri07 is hydrogen or Cι-C8alkyl, or Cι-C8alkyl substituted once, twice or three times by substituents selected from -COOH, Cι-C8alkoxycarbonyl and -CN, or R107 is C3-C8alkenyl, C3-C8alkynyl, phenyl or benzyl, wherein phenyl and benzyl may in turn be substituted from one to five times by substituents selected from halogen and Cι-C4alkyl and/or once, twice or three times by substituents selected from Ci-dhaloalkyl, Cι-C4alkoxy, -CN, -NO2, Cι-C4alkylthio, C C4alkylsulfmyl and Cι-C4alkylsulfonyl; or Ri06 and R107 together are d-dalkylene; Rιo8 is hydrogen, Cι-C4alkyl, Cι-C4haloalkyl or C3-C6cycloalkyl; R109 is hydrogen, Cι-C4alkyl, Cι-C4haloalkyl or C3-C6cycloalkyl; Riio is hydrogen, Cι-C8alkyl, C3-C8alkenyl, C3-C8alkynyl, d-C4haloalkyl or C3-C6haloalkenyl;
Rin is hydrogen or d-C8alkyl; Rn2 is hydrogen or Cι-C8alkyl, or Cι-C8alkyl substituted once, twice or three times by substituents selected from -COOH, Cι-C8alkoxycarbonyl and -CN; or Rn2 is C3-C8alkenyl, C3-C8alkynyl, phenyl or benzyl, wherein phenyl and benzyl may in turn be substituted from one to five times by substituents selected from halogen and Cι-C4alkyl and/or once, twice or three times by substituents selected from Cι-C4haloalkyl, C C4alkoxy, -CN, -NO2, Cι-C4alkylthio, Cι-C4alkylsulfmyl and Cι-C alkylsulfonyl; or Rin and Rπ2 together are d-dalkylene; Rn3 is hydrogen or Cι-C8alkyl;
Rπ4 is hydrogen, Cι-C8alkyl, -Si(Cι-C6alkyl)3, C3-C8alkenyl or C3-C8alkynyl; Rιi5 is Cι-C6alkyl;
Rιi6 is hydrogen, or d-dalkyl, C3-C8alkenyl or C3-C8alkynyl each of which may be substituted from one to five times by halogen and/or once, twice or three times by substituents selected from Cι-C4alkoxy and phenyl, wherein phenyl may in turn be substituted from one to five times by substituents selected from halogen and Cι-C alkyl and/or once, twice or three times by substituents selected from Cι-C4haloalkyl, d-Qalkoxy, -CN, -NO2, Cι-C4alkylthio, Cι-C4alkylsulfmyl and C C4alkylsulfonyl; Rιi7 is hydrogen or Cι-C8alkyl; Riis is hydrogen or Ci-Csalkyl, or Cι-C8alkyl substituted once, twice or three times by substituents selected from -COOH, Cι-C8alkoxycarbonyl and -CN; or Rns is C3-C8alkenyl, C3-C8alkynyl, phenyl or benzyl, wherein phenyl and benzyl may in turn be substituted from one to five times by substituents selected from halogen and Cι-C4alkyl and/or once, twice or three times by substituents selected from Cι-C4haloalkyl, Cι-C4alkoxy, -CN, -NO2, Cι-C4alkylthio, Cι-C4alkylsulfmyl and Cι-C4alkylsulfonyl; or Rιi7 and Rπ8 together are C2-C5alkylene;
Rn9 is hydrogen, Cι-C4alkyl, Cι-C4haloalkyl or C3~C6cycloalkyl; Rπo is hydrogen, Cι-C4alkyl, Cι-C4haloalkyl or C3-C6cycloalkyl; R121 is hydrogen, Cι-C8alkyl, C3-C8alkenyl, d-Qalkynyl, Cι-C4haloalkyl or C3-C6haloalkenyl; R122 is hydrogen or Cι-C8alkyl;
Ri23 is hydrogen or Cι-C8alkyl, or Cι-C8alkyl substituted once, twice or three times by substituents selected from -COOH, Cι-C8alkoxycarbonyl and -CN; or Rι23 is C3-C8alkenyl, C3-C8alkynyl, phenyl or benzyl, wherein phenyl and benzyl may in turn be substituted from one to five times by substituents selected from halogen and Cι-C4alkyl and/or once, twice or three times by substituents selected from
Cι-C4haloalkyl, Cι-C4alkoxy, -CN, -NO2, d-C4alkylthio, d-C4alkylsulfmyl and
C]-C4alkylsulfonyl; or
R122 and Ri23 together are C2-C alkylene; and
Rι is hydrogen or d-C8alkyl; A is a bridging member Ai, A2, A3, At or A5
wherein the bridging members Ai to A
5 are linked to the group Q at the end carrying the oxygen atom;
R131, R132, Ri33> Ri34, R135, Ri36, i37, i38, R139 and R]4o are each independently of the others hydrogen, halogen, -CN, -NO2, -N(R20o)R2oι, C C6alkyl, Cι-C6haloalkyl, -OH, Cι-C6alkoxy, Ci-Cβhaloalkoxy, C2-C6alkenyl, C2-C6haloalkenyl, C2-C6alkynyl, C3-C6alkenyloxy, C3-C6haloalkenyloxy, C3-C6alkynyloxy, C3-C8cycloalkyl, C3-C8halocycloalkyl, -C(O)OR202, -C(O)NR203R2o4, -C(S)NR205R2o6, -COR207, -CSR208, -C(R209)=NOR2ιo, -OC(O)R2π, -OC(0)OR2ι2, -SC(O)R2ι3, -SC(O)OR2ι4j -OC(S)SR2ι5, -SC(S)SR2ι6, -OSO2Cι-C6alkyl, -OS02Cι-C6haloalkyl, -SH, -S(O)qC C6alkyl or -S(O)qCι-C6haloalkyl, and/or
Ri3i, Ri32, R133, Ri34, i35, Ri36, i37, Ri38, Ri39 and R]40 may be each independently of the others Cι-C6alkyl or Cι-C6alkoxy each of which is substituted once, twice or three times by substituents selected from -CN, C(O)OR2ι7, -CHO, -COR2ι8, -C(O)NR2i9R22o, -C(S)NR22ιR222, -C(R223)=NOR224, -N(R225)R226, -OH, Cι-C6alkoxy, C,-C6haloalkoxy, -SH, -S(0)qCι-C6alkyl, -S(O)qCι-C6haloalkyl, -Si(CrC6alkyl)3, -Si(Cι-C6alkyl)r(phenyl)s and phenyl, wherein each phenyl ring may in turn be substituted from one to five times by substituents selected from halogen and Cι-C6alkyl and/or once, twice or three times by substituents selected from Cι-C6haloalkyl, -OH, Cι-C6alkoxy, Cι-C6haloalkoxy, -CN, -COR227, -COOR228, -N02, -N(R229)R23o, -SH, -S(O)qCι-C6alkyl and -S(O)qCι-C6haloalkyl; and/or
Ri3L R132, R133, R134, R135, Ri36, R137, i38, R139 and R! 0 may be each independently of the others phenyl or phenyl substituted from one to five times by substituents selected from halogen and Cι-C6alkyl and/or once, twice or three times by substituents selected from Cι-C6haloalkyl, -OH, d-C6alkoxy, Cι-C6haloalkoxy, -CN, -COR227, -COOR228, -N02, -N(R229)R230, -SH, -S(O)qC C6alkyl and -S(0)qCi-C6haloalkyl;
R20o and R20ι are each independently of the other hydrogen, Ci-dalkyl, Cι-C6haloalkyl, C2-C6alkenyl, C2-C6haloalkenyl, C2-C6alkynyl, C2-C6hydroxyalkyl, Cι-C6alkoxy- Cι-C6alkyl, phenyl or benzyl, wherein the two phenyl rings may be substituted from one to five times by substituents selected from halogen and Cι-C6alkyl and/or once, twice or three times by substituents selected from Cι-C6haloalkyl, -OH, Cι-C6alkoxy, Cι-C6haloalkoxy and -COR227;
R202 is hydrogen, Cι-C6alkyl, Cι-C6haloalkyl, C3-C6alkenyl, C -C6haloalkenyl, C3-C6alkynyl, C2-C6hydroxyalkyl, Cι-C6alkoxy-Cι-C6alkyl, phenyl or benzyl, wherein the two phenyl rings may be substituted from one to five times by substituents selected from halogen and Cι-C6alkyl and/or once, twice or three times by substituents selected from Cι-C6haloalkyl, -OH, Cι-C6alkoxy and Cι-C6haloalkoxy;
R203 and R20 are each independently of the other hydrogen, Cι-C6alkyl, d-C6haloalkyl, C2-C6alkenyl, d-dhaloalkenyl, C2-C6alkynyl, C2-C6hydroxyalkyl, Cι-C6alkoxy- C]-C6alkyl, phenyl or benzyl, wherein the two phenyl rings may be substituted from one to five times by substituents selected from halogen and Cι-C6alkyl and/or once, twice or three times by substituents selected from Cι-C6haloalkyl, -OH, Cι-C6alkoxy, C]-C6haloalkoxy and -COR227;
R205 and R2oδ are each independently of the other hydrogen, Cι-C6alkyl, Cι-C6halo alkyl, C2-C6alkenyl, C2-C6haloalkenyl, C2-C6alkynyl, C2-C6hydroxyalkyl, Cι-C6alkoxy- Cι-C6alkyl, phenyl or benzyl, wherein the two phenyl rings may be substituted from one to five times by substituents selected from halogen and Cι-C6alkyl and/or once, twice or three times by substituents selected from Cι-C6haloalkyl, -OH, Cι-C6alkoxy, Cι-C6haloalkoxy and -COR227;
R207 and R208 are each independently of the other hydrogen, Cι-C6alkyl, Cι-C6haloalkyl, C2-C6alkenyl, C2-C6haloalkenyl, C2-C6alkynyl, Cι-C6hydroxyalkyl, Cι-C6alkoxy- Cι-C6alkyl or phenyl, wherein the phenyl ring may be substituted from one to five times by substituents selected from halogen and Cι-C6alkyl and/or once, twice or three times by substituents selected from Ci-Qhaloalkyl, -OH, Cj-C6alkoxy, Cι-C6haloalkoxy, -CN, -COR227, -COOR228, -NO2, -N(R229)R23o, -SH, -S(O)qCι-C6alkyl and -S(0)qd-C6haloalkyl; R209 is hydrogen, Cι-C6alkyl, Cι-C6haloalkyl, C -C6alkenyl, C -C6haloalkenyl, C2-C6alkynyl, Cι-C6hydroxyalkyl, Cι-C6alkoxy-Cι-C6alkyl or phenyl, wherein the phenyl ring may be substituted from one to five times by substituents selected from halogen and Cι-C6alkyl and/or once, twice or three times by substituents selected from d-C6haloalkyl, -OH, Cι-C6alkoxy, C C6haloalkoxy, -CN, -COR227, -COOR228, -NO2, -N(R229)R23o, -SH, -S(O)qCι-C6alkyl and -S(O)qCι-C6haloalkyl; R2ιo is hydrogen, Cι-C6alkyl, CrC6haloalkyl, C3-C6alkenyl, C3-C6haloalkenyl,
C3-C6alkynyl, C2-C6hydroxyalkyl, Cι-C6alkoxy-Cι-C6alkyl, phenyl or benzyl, wherein the two phenyl rings may be substituted from one to five times by substituents selected from halogen and Cι-C6alkyl and/or once, twice or three times by substituents selected from Cι-C6haloalkyl, -OH, C C6alkoxy and d-C6haloalkoxy; R211 is hydrogen, Ci-Cόalkyl, Cι-C6haloalkyl, C2-C6alkenyl, C2-C6haloalkenyl, C2-C6alkynyl, Cι-C6hydroxyalkyl, Cι-C6alkoxy-Cι-C6alkyl or phenyl, wherein the phenyl ring may be substituted from one to five times by substituents selected from halogen and Cι-C6alkyl and/or once, twice or three times by substituents selected from Ci-Cδhaloalkyl, -OH, C C6alkoxy, C C6haloalkoxy, -CN, -COR227> -COOR228, -N02, -N(R229)R230, -SH, -S(O)qCι-C6alkyl and -S(0)qCi-C6haloalkyl;
R2ι2 is hydrogen, Cι-C6alkyl, Cι-C6haloalkyl, C3-C6alkenyl, C3-C6haloalkenyl, C3-C6alkynyl, C2-C6hydroxyalkyl, Ci-dalkoxy-Ci-Cόalkyl, phenyl or benzyl, wherein the two phenyl rings may be substituted from one to five times by substituents selected
from halogen and Cι-C6alkyl and/or once, twice or three times by substituents selected from Cι-C6haloalkyl, -OH, Cι-C6alkoxy and C]-C6haloalkoxy; R2i3 is hydrogen, Cι-C6alkyl, Cι-C6haloalkyl, C2-C6alkenyl, C2-C6haloalkenyl, C2-C6alkynyl, Cι-C6hydroxyalkyl, C!-C6alkoxy-Cι-C6alkyl or phenyl, wherein the phenyl ring may be substituted from one to five times by substituents selected from halogen and Cι-C6alkyl and/or once, twice or three times by substituents selected from Cι-C6haloalkyl, -OH, Cι-C6alkoxy, Cι-C6haloalkoxy, -CN, -COR227, -COOR228, -NO2, -N(R229)R230, -SH, -S(0)qCι-C6alkyl and -S(O)qCι-C6haloalkyl; R214, R215 and R2i6 are each independently of the others hydrogen, Cι-C6alkyl, d-C6halo- alkyl, C3-C6alkenyl, C3-C6haloalkenyl, C3-C6alkynyl, C2-C6hydroxyalkyl, Cι-C6alkoxy- Cι-C6alkyl, phenyl or benzyl, wherein the two phenyl rings maybe substituted from one to five times by substituents selected from halogen and Ci-Cδalkyl and/or once, twice or three times by substituents selected from Cι-C6haloalkyl, -OH, Cι-C6alkoxy and Cι-C6haloalkoxy; R2i7 is hydrogen, Cι-C6alkyL Cι-C6haloalkyl, C3-C6alkenyl, C3-C6haloalkenyl,
C3-C6alkynyl, C2-C6hydroxyalkyl, Cι-C6alkoxy-Cι-C6alkyl, phenyl or benzyl, wherein the two phenyl rings may be substituted from one to five times by substituents selected from halogen and C C6alkyl and/or once, twice or three times by substituents selected from Cι-C6haloalkyl, -OH, d-C6alkoxy and Cι-C6haloalkoxy; R2i8 is hydrogen, Cι-C6alkyl, Cι-C6haloalkyl, d-Qalkenyl, C3-C6haloalkenyl,
C3-C6alkynyl, C2-C6hydroxyalkyl, Cι-C6alkoxy-Cι-C6alkyl, phenyl or benzyl, wherein the two phenyl rings may be substituted from one to five times by substituents selected from halogen and Cι-C6alkyl and/or once, twice or three times by substituents selected from Cι-Cehaloalkyl, -OH, d-C6alkoxy and Cι-C6haloalkoxy; R2i9 is hydrogen, C]-C6alkyl, Ci-dhaloalkyl, C3-C6alkenyl, C3-C6haloalkenyl,
C3-C6alkynyl, C2-C6hydroxyalkyl, Cι-C6alkoxy-Cι-C6alkyl, phenyl or benzyl, wherein the two phenyl rings may be substituted from one to five times by substituents selected from halogen and Cι-C6alkyl and/or once, twice or three times by substituents selected from Cι-C6haloalkyl, -OH, d-C6alkoxy and Cι-C6haloalkoxy; R22o is hydrogen, d-C6alkyl, d-C6haloalkyl, C2-C6alkenyl, C2-C6haloalkenyl, C2-C6alkynyl, Cι-C6hydroxyalkyl, Cι-C6alkoxy-Cι-C6alkyl or phenyl, wherein the phenyl ring may be substituted from one to five times by substituents selected from halogen and d-C6alkyl and/or once, twice or three times by substituents selected from
d-C6haloalkyl, -OH, C C6alkoxy, C,-C6haloalkoxy, -CN, -COR227, -COOR228, -NO2, -N(R229)R230, -SH, -S(O)qCι-C6alkyl and -S(0)qCi-C6haloalkyl; R22ι is hydrogen, Cι-C6alkyl, Cι-C6haloalkyl, C -C6alkenyl, C3-C6haloalkenyl, C3-C6alkynyl, C2-C6hydroxyalkyl, C]-C6alkoxy-Cι-C6alkyl, phenyl or benzyl, wherein the two phenyl rings may be substituted from one to five times by substituents selected from halogen and Cι-C6alkyl and/or once, twice or three times by substituents selected from Cι-C6haloalkyl, -OH, Cι-C6alkoxy and Cι-C6haloalkoxy;
R222 is hydrogen, d-C6alkyl, d-C6haloalkyl, C2-C6alkenyl, C2-C6haloalkenyl,
C2-C6alkynyl, C2-C6hydroxyalkyl, Cι-C6alkoxy-Cι-C6alkyl or phenyl, wherein the phenyl ring may be substituted from one to five times by substituents selected from halogen and Cι-C6alkyl and/or once, twice or three times by substituents selected from
Cι-C6haloalkyl, -OH, Cι-C6alkoxy, Cι-C6haloalkoxy, -CN, -COR227, -COOR228, -NO2,
-N(R229)R23o, -SH, -S(O)qCι-C6alkyl and -S(O)qCι-C6haloalkyl;
R223 is hydrogen, Cι-C6alkyl, Cι-C6haloalkyl, C3-C6alkenyl, C3-C6haloalkenyl, C3-C6alkynyl, Cι-C6hydroxyalkyl, Cι-C alkoxy-Cι-C6alkyl, phenyl or benzyl, wherein the two phenyl rings may be substituted from one to five times by substituents selected from halogen and Cι-C6alkyl and/or once, twice or three times by substituents selected from Ci-Qhaloalkyl, -OH, d-C6alkoxy and Cι-C6haloalkoxy;
R 24 is hydrogen, Cι-C6alkyl, d-C6haloalkyl, C3-C6alkenyl, C3-C6haloalkenyl, C3-C6alkynyl, C2-C6hydroxyalkyl, Ci-dalkoxy-Ci-Cόalkyl, phenyl or benzyl, wherein the two phenyl rings may be substituted from one to five times by substituents selected from halogen and Cι-C6alkyl and/or once, twice or three times'by substituents selected from Ci-Qhaloalkyl, -OH, Ci-Qalkoxy and Cι-C6haloalkoxy;
R225 is hydrogen, Cι-C6alkyl, Cι-C6haloalkyl, C3-C6alkenyl, C3-C6haloalkenyl, C3-C6alkynyl, C2-C6hydroxyalkyl, Cι-C6alkoxy-Cι-C6alkyl, phenyl or benzyl, wherein the two phenyl rings may be substituted from one to five times by substituents selected from halogen and Cι-C6alkyl and/or once, twice or three times by substituents selected from C]-C6haloalkyl, -OH, Cι-C6alkoxy and d-C6haloalkoxy;
R226 is hydrogen, Cι-C6alkyl, Cι-C6haloalkyl, C2-C6alkenyl, C2-C6haloalkenyl, C2-C6alkynyl, C2-C6hydroxyalkyl, Cι-C6alkoxy-Cι-C6alkyl or phenyl, wherein the phenyl ring may be substituted from one to five times by substituents selected from halogen and Cj-C6alkyl and/or once, twice or three times by substituents selected from
d-C6haloalkyl, -OH, Cι-C6alkoxy, d-C6haloalkoxy, -CN, -COR227, -COOR228, -N02, -N(R229)R230, -SH, -S(O)qCι-C6alkyl and -S(O)qC C6haloalkyl;
R227 is hydrogen, Cι-C6alkyl, Cι-C6haloalkyl, C2-C6alkenyl, C2-C6haloalkenyl, C2-C6alkynyl, Cι-C6alkoxy-Cι-C6alkyl, phenyl or benzyl, wherein the two phenyl rings may be substituted from one to five times by substituents selected from halogen and
Cι-C6alkyl and/or once, twice or three times by substituents selected from d-C6haloalkyl, -OH, Cι-C6alkoxy and Cι-C6haloalkoxy;
R228 is hydrogen, C C6alkyl, Cι-C6haloalkyl, C3-C6alkenyl, C3-C6haloalkenyl,
C3-C6alkynyl, C2-C6hydroxyalkyl, Cι-C6alkoxy-Cι-C6alkyl, phenyl or benzyl, wherein the two phenyl rings may be substituted from one to five times by substituents selected from halogen and Cι-C6alkyl and/or once, twice or three times by substituents selected from Cι-C6haloalkyl, -OH, Cι-C6alkoxy and Cι-C6haloalkoxy;
R229 and R230 are each independently of the other hydrogen, Cι-C6alkyl, Cι-C6haloalkyl,
C2-C6alkenyl, C2-C6haloalkenyl, C2-C6alkynyl, C2-C6hydroxyalkyl, Cι-C6alkoxy- Cj-C6alkyl, phenyl or benzyl, wherein the two phenyl rings may be substituted from one to five times by substituents selected from halogen and Ci-Cδalkyl and/or once, twice or three times by substituents selected from CpCehaloalkyl, -OH, Cι-C6alkoxy, d-C6haloalkoxy and -COR227; q is 0, 1 or 2; r and s are 0, 1, 2 or 3, the sum of [r + s] being 3; or any one or more of those pairs of substituents Rι33 to Rι40 which are bonded to the same carbon atom together may form, each independently of any other(s), the function =O, =S, =NOR23ι or
=NN(R232)R233;
R23ι is hydrogen, Cι-C6alkyl, Cι-C6haloalkyl, C3-C6alkenyl, C -C6haloalkenyl, C3-C6alkynyl, C2-C6hydroxyalkyl, Cι-C6alkoxy-Cι-C6alkyl, phenyl or benzyl, wherein the two phenyl rings may be substituted from one to five times by substituents selected from halogen and C C6alkyl and or once, twice or three times by substituents selected from Cι-C6haloalkyl, -OH, Cι-C6alkoxy and Cι-C6haloalkoxy;
R2 2 and R233 are each independently of the other hydrogen, Cι-C6alkyl, Cι-C haloalkyl, C2-C6alkenyl, C2-C6haloalkenyl5 C2-C6alkynyl, C2-C6hydroxyalkyl, Cι-C6alkoxy-
Cι-C6alkyl, phenyl or benzyl, wherein the two phenyl rings may be substituted from one to five times by substituents selected from halogen and d-C6alkyl and/or once, twice or
three times by substituents selected from Cι-C6haloalkyl, -OH, Cι-C6alkoxy, Cι-C6haloalkoxy and -COR2 7; or - Ri3i and'Rι32 together, R133 and R]34 together, Rι35 and Rι36 together, R137 and Rι38 together and/or R09 and Rι40 together, each independently of any other(s), may form a C -C6alkylene or C2-C6alkenylene bridge each of which may be substituted from one to five times by substituents selected from halogen and d-C6alkyl and/or once, twice or three times by Cι-C6haloalkyl; and/or Rι3ι and Rι33 together, Rι33 and Rι35 together, R]35 and Rj37 together, and/or Rι37 and Rι39 together, each independently of any other(s), may form a Cι-C6alkylene or C -C6alkenylene bridge each of which may be substituted from one to five times by substituents selected from halogen and Cι-C6alkyl and/or once, twice or three times by Cι-C6haloalkyl; and/or R1 1 and R!35 together, Rι33 and Rι37 together, and/or R135 and Rι3g together, each independently of any other(s), may form a Cι-C6alkylene or C2-C6alkenylene bridge each of which may be substituted from one to five times by substituents selected from halogen and Cι-C6alkyl and/or once, twice or three times by Cι-C6haloalkyl; and/or R13ι and Rι37 together, Rι33 and R139 together, and/or Rι3] and Rι39 together, each independently of any other(s), may form a Cι-C6alkylene or C2-C6alkenylene bridge each of which may be substituted from one to five times by substituents selected from halogen and Cι-C6alkyl and/or once, twice or three times by Cι-C6haloalkyl, with the proviso that for Rι3ι and Rj32 the meanings -OH, -SH and -N(R2oo)R oι wherein R20o and R20ι are hydrogen are excluded; B either is a direct bond between the sp-hybridised carbon atom of the triple bond and the phenyl ring or is a bridging member Bi, B2, B3 or B
Ri
4i, i
4 , Ri
43, i44, j45, i46, i47 and R
]48 are each independently of the others hydrogen, halogen, -CN, -N0
2, -N(R
20o)R
2oι, C C
6alkyl, C C
6haloalkyl, -OH, Cι-C
6alkoxy, Cι-C
6haloalkoxy, C
2-C
6alkenyl, C
2-C
6haloalkenyl, C
2-C
6alkynyl, C
3-C
6alkenyloxy, d-Cghaloalkenyloxy, C
3-C
6alkynyloxy, C
3-C
8cycloalkyl, C
3-C
8halocycloalkyl, -C(O)OR
202, -C(O)NR
203R
204, -C(S)NR
205R
206, -COR
207, -CSR
208,
-OC(O)R
2n, -OC(0)OR
2ι
2, -SC(0)R
2ι
3, -SC(O)OR
2ι
4, -OC(S)SR
215, -SC(S)SR
216, -OSO
2Cj-C
6alkyl, -OSO
2C,-C
6haloalkyl
5 -SH, -S(O)
qCι-C
6alkyl or -S(0)
qCi-C
6haloalkyl, and/or Ri4i, R142, Ri43, Ri44, i4
5, Ri46, i47 and R]
48 may be each independently of the others Cι-C
6alkyl or Cι-C
6alkoxy each of which is substituted once, twice or three times by substituents selected from -CN, C(O)OR
2ι
7, -CHO, -COR
2ι
8, -C(O)NR
2i
9R2
2o, -C(S)NR
22ιR
222, -C(R
223)=NOR
22 , -N(R
225)R
22
6, -OH, C C
6alkoxy, d-C
6haloalkoxy, -SH, -S(O)
qd-C
6alkyl, -S(O)
qCι-C
6haloalkyl, -Si(d-C
6alkyl)
3, -Si(Cι-C
6alkyl)
r(phenyl)
s and phenyl, wherein each phenyl ring may in turn be substituted from one to five times by substituents selected from halogen and Cι-C
6alkyl and/or once, twice or three times by substituents selected from C]-C
6haloalkyl, -OH, Cι-C
6alkoxy, Cι-C haloalkoxy, -CN, -COR
227, -COOR
228, -NO
2, -N(R
229)R230, -SH, -S(0)
qCi-C
6alkyl and -S(0)
qCi-C
6haloalkyl, wherein R
200 to R
230, q, r and s are as defined hereinbefore; and/or R
HI, R
I4 , Rι
43, R]
44J RJ
45, Ri46, R147 and Rι
48 maybe each independently of the others phenyl or phenyl substituted from one to five times by substituents selected from halogen and Ci-Cβalkyl and/or once, twice or three times by substituents selected from Ci-Qhaloalkyl, -OH, Cι-C
6alkoxy, Cι-C
6haloalkoxy, -CN, -COR
227, -COOR
228, -N0
2, -N(R
229)R
23o, -SH, -S(0)
qCi-C
6alkyl and -S(0)
qCi-C
6haloalkyl; or any one or more of those pairs of substituents R
141 to R
148 which are bonded to the same carbon atom together may form, each independently of any other(s), the function =O, =S, =NOR
23] or =NN(R
23 )R
23 , wherein R
23i to R
23 are as defined hereinbefore; and/or R
14ι and Rj
42 together, Rι
43 and Rι
44 together, R
i 5 and Rι
46 together, and/or Rι
4 and Ri
48 together, each independently of any other(s), may form a C
2-C
6alkylene or C
2-C
6alkenylene bridge each of which may be substituted from one to five times by substituents selected from halogen and Cι-C
6alkyl and or once, twice or three times by d-dhaloalkyl; and/or
R
141 and R
i43 together, Rj
43 and Rι
45 together, and/or Rι
45 and R
i47 together, each independently of any other(s), may form a Cι-C
6alkylene or d-Qalkenylene bridge each
of which may be substituted from one to five times by substituents selected from halogen and d-C
6alkyl and/or once, twice or three times by d-dhaloalkyl; and/or Rι
4ι and Rι
45 together, Rι
4 and Rι
47 together, and/or R
] ι and R
] 7 together, each independently of any other(s), may form a Cι-C
6alkylene or C
2-C
6alkenylene bridge each of which may be substituted from one to five times by substituents selected from halogen and Cι-C
6alkyl and/or once, twice or three times by d-dhaloalkyl, and also to the compounds of formula I containing N-oxides of the groups Q
2, Q
3, Q
4, Q
5, Q
6, Q
7 and Q
8, the agrochemically acceptable salts and all stereoisomers and tautomers of the compounds of formula I, with the proviso that, when B is a direct bond between the sp-hybridised carbon atom of the triple bond and the phenyl ring, the bridging member A is other than
When n is 0, all free valencies on the aromatic and hetero aromatic groups Q to Q8 of the compounds of formula I are occupied by hydrogen. When m is 0, all free valencies on the phenyl ring of the compounds of formula I are occupied by hydrogen.
Examples of substituents that are formed as a result of R5 and R6 together, or Rι8 and R19 together, or R33 and R3 together, or R71 and R72 together, or R74 and R75 together being a C2-C5alkylene chain which may be interrupted by an oxygen or sulfur atom are piperidine, morpholine, thiomorpholine and pyrrolidine.
Examples of 5- to 7-membered heterocyclic ring systems which maybe aromatic or partially or fully saturated and may contain from 1 to 4 hetero atoms selected from nitrogen, oxygen and sulfur in the definition of R
2 are:
The alkyl groups appearing in the substituent definitions may be straight-chained or branched and are, for example, methyl, ethyl, n-propyl, isopropyl, n-butyl, sec-butyl,
' isobutyl, tert-butyl and the pentyl, hexyl, heptyl and octyl isomers. Preference is given to methyl, ethyl, n-propyl, isopropyl and n-butyl.
Halogen is fluorine, chlorine, bromine or iodine, preferably fluorine, chlorine or bromine.
Haloalkyl is, for example, fluoromethyl, difluoromethyl, trifluoromethyl, chloromethyl, ■ dichloromethyl, trichloromethyl, 2,2,2-trifluoroethyl, 2-fluoroethyl, 2-chloroethyl, pentafluoroethyl, l,l-difluoro-2,2,2-trichloroethyl, 2,2,3,3-tetrafluorόethyl or 2,2,2- trichloroethyl; preferably trichloromethyl, difluorochloromethyl, difluoromethyl, trifluoromethyl or dichlorofluoromethyl. In general, in cases where halogen is fluorine it is intended that, in addition to the specific definition "alkyl substituted from one to five times by halogen", perfluorinated
alkyl groups are also included; for example, in the definitions of Ri and R2 "Cι-C8alkyl substituted from one to five times by halogen" it is intended in addition that the perfluorinated alkyl groups are also included.
Where the number of halogen substituents on alkyl radicals is not specified, for example in the definitions of R6, Rι3 and R34 "Cι-C8alkylcarbonyl substituted by halogen" and in the definition of R41 "Cι-C8haloalkylcarbonyl", when halogen is chlorine, bromine and/or iodine Cι-C8alkylcarbonyl is substituted from one to five times but, when halogen is fluorine, it may be additionally substituted until perfluorinated. The other substituents which are not halogen, such as, for example, -CN, Cι-C6alkylamino or Cι-C4alkoxy, may occur on alkyl radicals once, twice or three times.
As haloalkenyl, alkenyl groups substituted one or more times by halogen are suitable, halogen being in particular bromine, iodine or, especially, fluorine or chlorine, for example 2- and 3-fluoropropenyl, 2- and 3-chloropropenyl, 2- and 3-bromopropenyl, 2,3,3-trifluoropropenyl, 2,3,3-trichloropropenyl, 4,4,4-trifluorobut-2-en-l-yl and 4,4,4- trichlorobut-2-en-l-yl. Among the alkenyl radicals substituted once, twice or three times by halogen, preference is given to those which have a chain length of '3 or 4 carbon atoms. The alkenyl groups may be halo-substituted at saturated or unsaturated carbon atoms.
Alkoxy groups have a chain length of preferably from 1 to 6, especially from 1 to 4, carbon atoms. Alkoxy is, for example, methoxy, ethoxy, propoxy, isopropoxy, n-butoxy, isobutoxy, sec-butoxy or tert-butoxy, or the pentyloxy and hexyloxy isomers; preferably methoxy or ethoxy.
Alkoxy, alkenyl, alkynyl, alkoxyalkyl, alkylthio, alkylsulfonyl, alkylsulfinyl, alkylthio- alkyl, alkylsulfmyl-alkyl, alkylsulfonyl-alkyl, alkylaminoalkoxy, alkoxycarbonyl, alkoxy-alkoxycarbonyl, alkenyloxycarbonyl, alkylcarbonyloxy, alkenylthio, alkenylsulfonyl, alkenylsulfinyl, alkynylsulfonyl, alkynylthio and alkynylsulfinyl groups are derived from the mentioned alkyl radicals. The alkenyl and alkynyl groups may be straight-chained or branched and mono- or poly-unsaturated. Alkenyl is, for example, vinyl, allyl, methallyl, 1-methylvinyl, but-2-en-l-yl, pentenyl or 2-hexenyl, preferably an alkenyl radical having a chain length of from 2 to 5 carbon atoms.
Alkynyl is, for example, ethynyl, propargyl, 1-methylpropargyl, 3-butynyl, but-2-yn-l-yl, 2-methylbutyn-2-yl or but-3-yn-2-yl, preferably an alkynyl radical having a chain length of 3 or 4 carbon atoms.
Alkylthio groups preferably have a chain length of from 1 to 4 carbon atoms. Alkylthio is, for example, methylthio, ethylthio, propylthio, isopropylthio, n-butylthio, isobutylthio, sec-butylthio or tert-butylthio, preferably methylthio or ethylthio. Alkylsulfinyl is, for example, methylsulfinyl, ethylsulfinyl, propylsulfinyl, isopropylsulfinyl, n-butylsulfinyl, isobutylsulfmyl, sec-butylsulfinyl or tert-butylsulfinyl; preferably methylsulfinyl or ethylsulfinyl. Alkylsulfonyl is, for example, methylsulfonyl, ethylsulfonyl, propylsulfonyl, isopropylsulfonyl, n-butylsulfonyl, isobutylsulfonyl, sec-butylsulfonyl or tert-butylsulfonyl; preferably methylsulfonyl or ethylsulfonyl.
Hydroxyalkyl is, for example, 2-hydroxyethyl, 3 -hydroxypropyl or 2,3-dihydroxypropyl.
Haloalkoxy is, for example, fluoromethόxy, difluoromethoxy, trifluoromethoxy, 2,2,2- trifluoroethoxy, 1,1,2,2-tetrafluoroethoxy, 2-fluoroethoxy, 2-chloroethoxy or 2,2,2- trichloroethoxy.
Alkoxyalkyl groups preferably have from 1 to 6 carbon atoms. Alkoxyalkyl is, for example, methoxymethyl, methoxyethyl, ethoxymethyl, ethoxyethyl, n-propoxymethyl, n-propoxyethyl, isopropoxymethyl or isopropoxyethyl.
Cycloalkyl radicals that are suitable as substituents are, for example, cyclopropyl, cyclobutyl, cyclopentyl and cyclohexyl.
The cycloalkyl groups may be unsubstituted or substituted a number of times by halogen, especially from once to four times by fluorine, chlorine and/or bromine, for example, diffuorocyclopropyl, dichlorocyclopropyl, dibromocyclopropyl, 2,2,3,3- tetrafluorocyclobutyl and 2,2-difluoro-3,3-dichlorocyclobutyl.
Alkylamino is, for example, methylamino, ethylamino, n-propylamino, isopropylamino or the butylamino isomers.
Dialkylamino is, for example, dimethylamino, diethylamino or the dipropyl- or dibutyl- amino isomers.
Substituents where two adjacent Ri substituents (on the group Oj, Q2, Q3, Q4, Q5 or Q7) together form a Ci-dalkylene bridge which may be interrupted by from 1 to 3 hetero atoms selected from oxygen, nitrogen and sulfur and/or which may be substituted from one to five times by halogen and/or by Cι-C6alkyl and/or once, twice or three times by Cι-C6alkoxy, the total number of ring atoms being at least 5 and at most 9, or where two adjacent R substituents together form a C2-dalkenylene bridge which may be interrupted by from 1 to 3 hetero atoms selected from oxygen, nitrogen and sulfur and/or which may be substituted from one to five times by halogen and/or by Cι-C6alkyl and/or once, twice or three times by Cι-C6alkoxy, the total number of ring atoms being at least 5 and at most 9, have, for example, the following structures:
Substituents where two adjacent R substituents together form a Cj-dalkylene bridge which may be interrupted by from 1 to 3 hetero atoms selected from oxygen, nitrogen
. and sulfur and/or which may be substituted from one to five times by substituents selected from halogen and Cι-C
6alkyl and/or once, twice or three times by Cι-C
6alkoxy, the total number of ring atoms being at least 5 and at most 9, or where two adjacent R
2 substituents together form a d-dalkenylene bridge which may be interrupted by from 1 to 3 hetero atoms selected from oxygen, nitrogen and sulfur and which may be substituted from one to five times by substituents selected from halogen and Cι-C
6alkyl and or once, twice or three times by Cι-C
6alkoxy, the total number of ring atoms being at least 5 and at most 9, have, for example, the following structures:
Meanings corresponding to those indicated above may also be given to the substituents in combined definitions, for example alkoxycarbonyl, alkoxy-alkoxycarbonyl, alkylsulfonyl-alkyl, -N(R56)SO2R57, -OC^NR^o, -C(R38)=NOR39, -NR50SO2R5ι and -NR52CO2R53.
In the definitions for alkylcarbonyl, alkoxycarbonyl and alkenyloxycarbonyl, the carbon atom of the carbonyl is not included in the lower and upper limits given for the number of carbons in each particular case.
The invention relates also to the salts which the compounds of formula I are able to form preferably with amines, alkali metal and alkaline earth metal bases or quaternary ammonium bases. Suitable salt formers are described, for example, in WO 98/41089.
Among the alkali metal and alkaline earth metal hydroxides as salt formers, special mention should be made of the hydroxides of lithium, sodium, potassium, magnesium and calcium, but especially the hydroxides of sodium and potassium.
Examples of amines suitable for ammonium salt formation include ammonia as well as primary, secondary and tertiary Cι-Cι8alkylamines, Cι-C4hydroxyalkylamines and C2-C4alkoxyalkylamines, for example methylamine, ethylamine, n-propylamine, isopropylamine, the four butylamine isomers, n-amylamine, isoamylamine, hexylamine, heptylamine, octylamine, nonylamine, decylamine, pentadecylamine, hexadecylamine, heptadecylamine, octadecylamine, methyl-ethylamine, methyl-isopropylamine, methyl- hexylamine, methyl-nonylamine, methyl-pentadecylamine, methyl-octadecylamine, ethyl-butylamine, ethyl-heptylamine, ethyl-octylamine, hexyl-heptylamine, hexyl- octylamine, dimethylamine, diethylamine, di-n-propylamine, diisopropylamine, di-n- butylamine, di-n-amylamine, diisoamylamine, dihexylamine, diheptylamine, dioctylamine, ethanolarmne, n-propanolamine, isopropanolamine, N,N-diethanolamine, N-ethylpropanolamine, N-butylethanolamine, allylamine, n-butenyl-2-amine, n-pentenyl- 2-amine, 2,3-dimethylbutenyl-2-amine, dibutenyl-2-amine, n-hexenyl-2-amine, propylenediamine, trimethylamine, triethylamine, tri-n-propylamine, triisopropylamine, tri-n-butylamine, triisobutylamine, tri-sec-butylamine, tri-n-amylamine, methoxyethylamine and ethoxyethylamine; heterocyclic amines, for example pyridine, quinoline, isoquinoline, morpholine, piperidine, pyrrolidine, indoline, quinuclidine and azepine; primary arylamines, for example anilines, methoxyanilines, ethoxyanilines, o-, m- and p-toluidines, phenylenediamines, benzidines, naphthylamines and o-, m- and p- chloroanilines; but especially triethylamine, isopropylamine and diisopropylamine.
Preferred quaternary ammonium bases suitable for salt formation correspond, for example, to the formula [N(RaRbRcRd)]OH wherein Ra, Rb, Re and Ra are each independently of the others Cι-C4alkyl. Other suitable tetraalkylammonium bases with other anions can be obtained, for example, by anion exchange reactions.
In addition to the formation of salts of compounds of formula I having acid hydrogen, especially of the derivatives having carboxylic acid groups (e.g. carboxyl-substituted alkyl, cycloalkyl, alkenyl and alkynyl groups for Ri, or aromatic or heteroaromatic rings substituted by Ri (-CO2R7) or aromatic rings substituted by R (-CO2R35), wherein R7 and R35 are hydrogen), or HON=CH- or mercapto-substituted phenyl rings (R2 is
-C(R
38)=NOR
39 or -SR
42, wherein R
9 and R42 are hydrogen), salts of the compounds of formula I having basic groups are also possible, especially having basic pyridyl, pyrimidyl, pyrazinyl and pyridazinyl rings (Q
2 to Q
8) or having amino or hydrazino groups as in, for example, the definition of Rj and R
2, and R
133 to Rι
40 and R
141 to R
!48
Such salts are, for example, salts with inorganic and organic acids such as, for example, hydrohalic acids, e.g. hydrofluoric acid, hydrochloric acid, hydrobromic acid or hydriodic acid, and sulfuric acid, phosphoric acid and nitric acid, and organic acids such as acetic acid, trifluoroacetic acid, trichloroacetic acid, propionic acid, glycolic acid, thiocyanic acid, citric acid, benzoic acid, oxalic acid, formic acid, benzenesulfonic acid, p-toluenesulfonic acid and methanesulfonic acid.
The presence of an asymmetric carbon atom or of a sulfmyl group in the compounds of formula I, for example when the substituent Ri or R2 is a branched alkyl, alkenyl or haloalkyl group or alkylsulfmyl, means that the compounds may occur either in the form of optically active single isomers or in the form of racemic mixtures. In the present invention, the compounds of formula I are understood to include both the pure optical antipodes and the racemates and diastereoisomers.
When an aliphatic C=C double bond or a HON=CH group is present, e.g. -C(R2 )=NOR25 wherein R24 and R25 are hydrogen, geometric isomerism may occur. Such isomers are also included in the present invention.
Preference is given to compounds of formula I wherein Q is a group Qi, Q2, Q3 or Q
Amongst those compounds, special preference is given to those wherein Q is a group Q or Q2
(R (Q
2).
especially wherein Q is a group Qi
Special preference is likewise given to compounds of formula I wherein Q is a group Q2a or Q4a
Preference is given to those compounds of formula I wherein A is a bridging member Ai or A2
Preference is also given to those compounds of formula I wherein B is a direct bond between the sp-hybridised carbon atom of the triple bond and the phenyl ring or is the
R141 ,
R1142 / ( J. bridging member B}
Preference is furthermore given to those compounds of formula I wherein A is a bridging R-I33 R \ / 134 member A2 and B is a direct bond between the sp- (A2) R131 R 32 hybridised carbon atom of the triple bond and the phenyl ring.
Of importance are those compounds of formula I wherein A is the bridging member Ai
Likewise of importance are those compounds of formula I wherein Q is a group Q , Q2, Q3 or Q4
A i
s the bridging member A
2 and B is a direct bond between the sp-hybridised carbon atom of the triple bond and the phenyl ring.
Important compounds of formula I are also those wherein Q is a group Q , Q
2, Q
3 or Q
4
A
is the bridging member Ai and B is the bridging member
Also of importance are compounds of formula I wherein Q is a group Qi or Q2
/ \ (A2),
A is the bridging member A2 R113311 R132 and B is a direct bond between the sp-hybridised carbon atom of the triple bond and the phenyl ring.
Important compounds of formula I are those wherein Q is a group Qi or Q2
is the bridging member Aj
(B,). and B is the bridging member Bi
Likewise of importance are those compounds of formula I wherein each R1 } independently of any other(s), is halogen, -CN, -N02, -C(R1o)=NORπ, -OR13, -SO2Rι6, -OSO2R17, Cι-C8alkyl or C2-C8alkenyl, or Cι-C8alkyl substituted once, twice or three times by halogen and/or by -CN; Rio is hydrogen or C1-C4alkyl; Rn is Cι-C8alkyl, and n is O, 1, 2 or 3.
Especially important compounds of formula I are those wherein each R2, independently of any other(s), is halogen, -CN, -SCN, -OCN, -N3, -NO2, -NR33R34, -CO2R35,
-CONR36R37, -C(R38)=NOR39, -COR40, -OR41, -SO2R44, -OSO2R45, -N([CO]pR46)COR47, -N(R56)S02R57, -N(SO2R58)SO2R59, -N=C(OR60)R6i or Cι-C8alkyl, or Cι-C8alkyl substituted once, twice or three times by halogen, -CN, -N , -SCN, -CO2R73, -CONR74R7;;, -COR76, -C(R77)=NOR78, -C(S)NR79R80, -OR82, -SOR84, -SO2R85 and/or by -N(R89)COR90, and m is 0, 1 , 2, 3 or 4.
The compounds of formula I
wherein Q, A, B, R
2 and m are as defined hereinbefore, may be prepared by various known processes. The groups Qi to Q
8, the phenyl ring, and their substituents Ri (on groups Qi to Q
8) and R2 (on the phenyl ring), and also the substituents of the bridging members A (R
131 to Rι
40) and B (Rj
4ι to Rι
48) do not restrict those processes; on the contrary, they can be taken into account in synthesis planning so that particular procedures can be used preferentially and carried out selectively and with a high yield. This will be the case, for example, when the substituents Ri and/or R
2 have an activating and/or directing influence, by way of electron-withdrawing or -releasing effects or steric effects, such as, for example, in the nucleophilic aromatic substitution reaction of compounds of formula VIIi
with an alcoholate of formula Xai, Xa , Xa
3, Xa
4 or Xa
5
or in the nucleophilic ring opening of the epoxide of formula Vb
2
by the acetylide of the compound of formula Ila (Ila).
In general, the substituents Ri and/or R
2, and also the substituents of the bridging members A and B (Rι
3ι to R
1 o, and R
141 to R
!48) have little influence, for example, on the palladium-catalysed cross-coupling of propargyl derivatives of formula Ila
wherein Q and A are as defined for formula I, with substituted phenyl derivatives of formula III
wherein R
2 and m are as defined for formula I and W is halogen or a sulfonate, for example trifluoromethanesulfonate, in accordance with K. Sonogashira, or in the Mitsunobu reaction of the compound of formula VII Q-OH (VII), wherein Q is as defined for formula I, with the alkynyl-alcohol of formula VIII
wherein A, B, R
2 and m are as defined for formula I, in the presence of azodicarboxylic acid diethyl ester (DEAD) or N,N,N',N'-tetramethylazodicarboxamide (TMAD) and triphenylphosphine.
Those two important coupling reactions are illustrated in Reaction Scheme 1.
Reaction Scheme 1 : Sonogashira and Mitsunobu coupling reactions
A Q
The substituents Ri and/or R2, for example in compounds of formulae Ila, lib, III, IVbi to TVb4, Vb2 to Vb4, Vlai to Via* VII, VIIi, VIII, IXai to IXa5, Xai to Xa5, XIa3 to XIa5, XV, XlXajbo to XIXa5b0, XXIa3b to XXIa5b, XXIIIabi to XXIIIab4 or XXVa2b to XXVa5b can already be present at the outset or, however, they may be successively introduced only later in the reaction sequence, for example by means of nucleophihc or electrophilic aromatic substitution.
For preparation of the compound of formula I and the corresponding intermediates, for example of formulae Ila and XV
wherein A and Q are as defined for formula I and E is an electrophilic functional group, the following bonds shown in Scheme 2, for example, are suitable retrosynthetically as attachment sites:
Scheme 2: Retrosynthesis of compounds of formula I and their intermediates
The attachment sites shown retrosynthetically in Scheme 2 in general terms for the synthesis of the compounds of formula I and the intermediates of formulae Ila, XV, XLXaibo to XIXa5b0, XXIa3b to XXIa5b, XXIIIab2 to XXIIIab4 and XXVa2b to XXVa5b are described in detail below.
In accordance with Reaction Scheme 1, the compounds of formula Iab0
wherein A, Q, R
2 and m are as defined for formula I, may be prepared analogously to known processes described, for example, in K. Sonogashira, Comprehensive Organic Synthesis 1991, Vol. 3, page 521 ff; WO 01/55066; WO 02/28182 and WO 03/013247, by, for example, coupling a compound of formula Ila
wherein A and Q are as defined, with a compound of formula III
wherein 2 and m are as defined and W is a leaving group such as, for example, halogen, e.g. iodine, or sulfonate, e.g. trifluoromethanesulfonate, in the presence of a palladium catalyst under Sonogashira reaction conditions (Reaction Scheme 1). Suitable catalyst mixtures are, for example, tetrakis(triphenylphosphine)palladium or bis(triphenylphosphine)palladiurn dichloride together with copper iodide. As bases for reductive elimination, amines, e.g. triethylamine, diethylamine or diisopropylethylamine, are preferably used. The aryls of formula III preferably carry a leaving group W wherein W is, for example, halogen (N. Krause et ai, J. Org. Chem. 1998, 63, page 8551; and H. Nakamura et al., Tetrahedron Lett. 2000, 41, page 2185) or trifluoromethanesulfonate (K. Ritter, Synthesis 1993, page 735). As solvents there are usually used ethers, e.g. tetrahydrofuran or dioxane, chlorinated hydrocarbons, e.g. chloroform, or dipolar aprotic solvents, e.g. dimethylformamide or dimethyl sulfoxide, or also amines, e.g. triethylamine or piperidine.
The compounds of formula Iabi, Iab2, Iab3 or Iab4
wherein A, Q, R , m and Rj
43 to Rι
48 are as defined for formula I and Ej is a bridging member \ \ \
R141 \ ^
R141 .C=0 or /
C"OH / NHR wherein R
1 ι is as defined for formula I and Rj
49 is hydrogen, d-dalkyl, Cι-C
6haloalkyl, C
2-C
6alkenyl, C -C
6haloalkenyl, C
2-C
6alkynyl, C
2-C
6hydroxyalkyl, Cι-C
6alkoxy-C]-C
6alkyl, phenyl or benzyl, wherein the two phenyl rings may be substituted from one to five times by substituents selected from halogen and Cι-C
6alkyl and/or once, twice or three times by substituents selected from Cι-C
6haloalkyl, -OH, Cι-C
6alkoxy, Ci-Qhaloalkoxy and -COR22
7, wherein R
227 is as defined for formula I, may be prepared analogously to known processes described, for example, in J. Org. Chem. 68(2), 348-354 (2003); Synth. Communic. 32(13), 1937-45 (2002); Tetrahedron: Asymmetry 12(1), 53-57 (2001); Organic Letters 3(6), 819-21 (2001); Tetrahedron Lett. 43(15), 2691-94 (2002); Acta Chemica Scandinavica 49(7), 543-45 (1995); Synlett (1), 66-68 (1989); and Helv. Chim. Acta 72(3), 447-56 (1989), by, for example, reacting a compound of formula Ila
wherein A and Q are as defined, with a compound of formula IVbi, IVb
2, IVb
3 or IVb
4
wherein R
2, m and Rι
43 to Rι
48 are as defined and E is an electrophilic functional group
wherein R
1 1 and R
14 are as defined and Xi is a leaving group, for example halogen, e.g. fluorine, chlorine, bromine or iodine, or sulfonate, e.g. para-toluenesulfonate (-OTs, tosylate), methanesulfonate (-OMs, mesylate) or trifluoromethanesulfonate (-OTf, triflate), CH
3(CH
3O)N-, imidazolyl, triazolyl, -OR4, -SR
4 or -N(R
4)
2, wherein R
4 is d-C
6alkyl, Cι-C
6haloalkyl or phenyl, in the presence either a) of a strong base or b) of zinc salts and a base in an inert, organic solvent at temperatures from -100° to 50°C. As a strong base for variant a) for the formation of the corresponding acetylide there are suitable, for example, organolithium compounds, e.g. n-butyllithium (n-BuLi), lithium diisopropylamide (LDA) or lithium bis(trimethylsilyl)amide ([(CH
3)
3Si]
2NLi), or a Grignard reagent, e.g. ethyl magnesium bromide. Suitable inert organic solvents are, for example, ethers, e.g. diethyl ether, tetrahydrofuran, or hexane-ether mixtures, or chlorinated hydrocarbons, e.g. dichloromethane. In accordance with variant b), the acetylene function in the compound of formula Ila is activated by means of zinc salts, e.g. zinc trifluoromethanesulfonate (CF
3SO
3)
2Zn, in the presence of a base, e.g. triethylamine or Hϋnig's base, in analogous manner to that
described in Tetrahedron Lett. 43(15), 2691-94 (2002); and J. Am. Chem. Soc. 121(48), 11245-246 (1999).
'
The compounds of formula Iab2, Iab3 or Iab4
wherein A, Q, R
2, m and R
145 to R
148 are as defined for formula I and E
2 is a bridging
member , wherein R
1 1, Rι
42 and Rι
43 are as defined for formula I,
may be prepared analogously to known processes described, for example, in Organic Letters 4(25), 4427-29 (2002); Heterocycles 42(2), 745-74 (1996); and Tetrahedron Lett. 33(37), 5365-68 (1992) and also processes mentioned hereinbefore, by, for example, causing a compound of formula Ila
wherein A and Q are as defined, to react with a compound of formula Vb
2, Vb
3 or Vb
wherein R
2, m, Rj
4ι to Rι
43, and Rι
5 to R
]48 are as defined, in the presence a) of a strong base or b) of zinc salts and a base in an inert, organic solvent at temperatures from -100° to 50°C.
As a strong base for variant a) for the formation of the corresponding acetylide there are suitable, for example, organolithium compounds, e.g. n-butyllithium (n-BuLi). Suitable inert organic solvents are, for example, ethers, e.g. tetrahydrofuran, or chlorinated hydrocarbons, e.g. dichloromethane.
In the process, the epoxy functionality in the compound of formula Vb2 to Vb4 is a substitute for the electrophilic functional group E in the compound of formula IVbi to rVb4, which reacts with the acetylide or the zinc-activated compound of formula lib
The addition of the acetylides of compounds of formula Ila to the epoxides of formula Vb2 to Vb4, especially to the epoxide of formula Vb2, may, depending on the substituents Rι41 to Rι43 and R2 and on the reaction conditions, for example in the presence of Lewis acids, result in isomeric mixtures. Those isomeric mixtures can be resolved by customary methods, e.g. by means of column chromatography.
Compounds of formula I
wherein A, Q, B, R
2 and m are as defined under formula I, may be prepared using the Mitsunobu reaction in the presence of azodicarboxylic acid diethyl ester (DEAD) and triphenylphosphine in a suitable solvent such as, for example, an ether, e.g. tetrahydrofuran (THF), in a manner analogous to that described, for example, in Synthetic Communic. 1989(19), 1255-59; or Synthesis 1981(1); or, using TMAD reagent as a substitute for DEAD in the two previous references, in a manner analogous to that described, for example, in Chem. Letters 1994, 539 (Reaction Scheme 1). That synthesis route uses, as intermediates, the compound of formula VII Q-OH (VII) and the alkynyl-alcohol of formula VIII
which are caused to react with one another under typical Mitsunobu reaction conditions, the radicals A, Q, B and R
2 and the suffix m in the compounds of formulae VII and VIII being as defined.
The Mitsunobu reaction is especially advantageous for those compounds of formula VII in which Q is a group Qj or a group Q2, Q or Q5, the hydroxyl function in the latter three groups advantageously being in a position other than a position ortho to a ring nitrogen atom.
A further possibility for the preparation of compounds of formula I
wherein A, Q, B, R
2 and m are as defined for formula I, is the base-catalysed alkylation or etherification of a compound of formula VII Q-OH (VII)
with a compound of formula IXai, IXa
2, IXa
3, IXa
4 or IXa
5
under reaction
conditions typical therefor, the radicals Q, B and R
2 and the suffix m in the compounds of formulae VII and IXai to IXa
5 being as defined, R
131 to R
140 being as defined for formula I and L being a leaving group such as, for example, halogen, e.g. chlorine, bromine or iodine, acetate, or sulfonate, e.g. mesylate, tosylate or triflate.
Suitable bases are, for example, hydrides such as, for example, alkali metal and alkaline earth metal hydrides, e.g. sodium or potassium hydride, hydroxides such as, for example, alkali metal hydroxides, e.g. sodium or potassium hydroxide, alcoholates, e.g. sodium methanolate, sodium ethanolate or potassium tert-butanolate, carbonates, e.g. potassium or calcium carbonate, amines, e.g. triethylamine, or also sodium bis(trimethylsilyl)amide
(NaN[(CH3)3Si]2), silver© oxide (Ag2O) or Ag(OH)2.
Suitable solvents are amides, e.g. N,N-dimethylformamide, or nitriles, e.g. acetonitrile.
Such etherification procedures are standard processes and may be carried out, for example, in analogy to J. Chem. Soc, Perkin Trans I, 1979, 2756-61; Synth. Communic. 18, 1111-18 (1988); Chem. Communic. 1990, 297-300; J. Org. Chem. 61, 4258-61 (1996); Tetrahedron 1997(53), 12621-628; and Synth. Communic. 24, 1367-79 (1994). Selective O-alkylation procedures in the presence of a ring nitrogen atom maybe carried out in a manner analogous to that described, for example, in Synth. Communic. 1994(24), 1367 and Heterocycles 1990(31), 819, and also in halogenated or aromatic hydrocarbons as solvent, e.g. chloroform or toluene, in the presence of silver carbonate as base.
The activation of the alcohol of formula VIII to form the compound of formula IXai to IXa5 is carried out, for example, by sulfonylation or halogenation. Sulfonylation of the alcohol of formula VIII is a standard reaction and may be carried out, for example, using a sulfonic acid chloride, e.g. mesyl chloride or para- toluenesulfonic acid chloride (p-TosCl), in the presence of a tertiary amine, e.g.. triethylamine, or of an aromatic amine, e.g. pyridine, in a solvent such as, for example, a chlorinated hydrocarbon, e.g. carbon tetrachloride or methylene chloride, or an amine, e.g. pyridine. Such reactions are generally known and described, for example, in J. Org. Chem. 1997 (62), 8987; J. Het. Chem. 1995 (32), 875-882; and also Tetrahedron Lett. 1997 (38), 8671-8674.
Halogenation of the alcohol of formula VIII may be carried out in analogy to standard processes. For example, bromination may be carried out using carbon tetrabromide in the presence of triphenylphosphine (Synthesis 1998, 1015-1018) in methylene chloride. Chlorination may be carried out using mineral acids, e.g. concentrated hydrochloric acid (J. Org. Chem. 1955 (20), 95), or using para-toluenesulfonic acid chloride in the presence of an amine, e.g. triethylamine, in a solvent, e.g. methylene chloride (Tetrahedron Lett. 1984 (25), 2295).
A further general method for the preparation of compounds of formula I
wherein A, Q, B, R
2 and m are as defined for formula I, comprises, by means of a nucleophilic aromatic substitution reaction, causing the compound of formula VIIi
to react with an alcoholate of formula Xai, Xa , Xa
3, Xa
4 or Xa
5
under typical substitution reaction conditions, the radicals Q, B and R
2 and the suffix m in the compounds of formulae VIIi and Xai to Xa
5 being as defined, R
13ι to Rι
40 being as defined for formula I, Li being a leaving group such as, for example, halogen, e.g. fluorine (for Q = Q
2 to Q
8), chlorine, bromine or iodine, or a sulfonate, e.g. -OTosyϊ (-OTs) or -OMesyl (-OMs), an alkylsulfonyl (for Q = Q
2 to Q
8), e.g. CH
3SO
2-, imidazolyl, triazolyl, -SCH
3 or phenoxy, and M
+ being an alkali metal ion, e.g. Na
+. For compounds of formula VII] wherein Q is a group Qi, the nucleophilic aromatic substitution reaction is facilitated if they are activated compounds. That is the case when
Ri is, for example, a substituent having electron-withdrawing properties (-M and/or -I effect), for example -CN, -NO
2, -C0
2R7 or CORj
2, or when the leaving group L
\ in the groups Q
2 to Q
8 is in a position ortho to a ring nitrogen atom. Such substitution reactions with activated compounds of formula VIIi wherein Q is a group Qi to Q
8 and Rj is a substituent having an -M and/or -I effect within the framework of the definition of Ri given for formula I, are standard methods and may be carried out, for example, in analogy to Synlett 2000, 874-876; ibid 1998, 794-796; or J. Org. Chem. 1998(63), 9594- 96.
For non-activated compounds of formula VII], wherein Q is, for example, a group Qi, and Ri is, for example, a substituent without electron- withdrawing properties (+M and/or +1 effect) such as, for example, -NR Rό or -ORι3, a suitable alternative synthesis method is the above-mentioned base-catalysed alkylation or etherification of a compound of formula VII with a compound of formula IXai to IXa5.
The compounds of formula Ia2b, Ia3b, Ia4b or Ia5b
wherein Q, B, R
2, m and Rι
3] to Rι
38 are as defined for formula I and E
3 is a bridging member
\ ,
R139 oH
' °
r
wherein Rj
33, Rι
35, Rι
37 and Rι
39 are as defined for formula I and Rι
4 is hydrogen, Cι-C
6alkyl, Cι-C
6haloalkyl, C
2-C
6alkenyl, C
2-C
6haloalkenyl, C
2-C
6alkynyl, C -C
6hydroxyalkyl, d-C
6alkoxy-Cι-C
6alkyl, phenyl or benzyl, wherein the two phenyl rings may be substituted from one to five times by substituents selected from halogen and Cι-C
6alkyl and/or once, twice or three times by substituents selected from Cι-C
6haloalkyl, -OH, Cι-C
6alkoxy, Cι-C
6haloalkoxy and -COR
227, wherein R
227 is as defined for formula I, may be prepared analogously to routes that are known and described hereinbefore for compounds of formula Iabi, Iab
2, Iab or Iab
4, by causing a compound of formula Vlai , VIa
2, VIa
3 or VIa
4
R 131 R
11
S32 Q- O E (Via,),
to react with a compound of formula lib
in the presence a) of a strong base or b) of zinc salts and a base in an inert organic solvent at temperatures from -100° to 50°C, the radicals Q, B, R
2 and Ri
3i to Rι
38 and the suffix m in the compounds of formulae Vlai to VI^ and lib being as
defined and E being an electrophilic functional group
wherein Rι
33, Rι
3 , Rι
7, Rj
39 and Rι
49 are as defined and Xi is a leaving group such as, for example, halogen, e.g. fluorine, chlorine, bromine or iodine, or sulfonate, e.g. para- toluenesulfonate (-OTs, tosylate), methanesulfonate (-OMs, mesylate) or trifluoromethanesulfonate (-OTf, triflate), or CH
3(CH
3O)N-, imidazolyl, triazolyl, -OR
4, -SR
4 or -N(R )
2, wherein R
4 is Cι-C
6alkyl, Cι-C
6haloalkyl or phenyl.
The compound of formula Ia3b, Ia b or Ia5b
wherein Q, B, R
2, m and R
131 to Rι
36 are as defined for formula I and E
4 is a bridging member ,
R133 and R135 to R]40 being as defined for formula I, can also be prepared analogously to the above-described process. In accordance therewith, an epoxide derivative of formula XIa3, X^ or XIa5
is caused to react with a compound of formula lib
in the presence a) of a strong base or b) of zinc salts and a base in an inert organic solvent at temperatures from -100° to 50°C, the radicals Q, B, R
2 and R
131 to Rι
40 and the suffix m in the compounds of formulae XIa
3 to XIa
5 and lib being as defined.
In the process, the epoxy functionality is a substitute for the electrophilic functional group E in the compounds of formulae Vlai to VIa in the previous example, which reacts with the acetylide or the zinc-activated compound of formula lib.
The intermediate of formula Ila
wherein A and Q are as defined for formula I, may be prepared by means of the Mitsunobu reaction already described in detail hereinbefore (Reaction Scheme 1) from the compound of formula VII Q-OH (VII) and the compound of formula XII
the radicals A and Q in the compounds of formulae VII and XII being as defined.
A further method for the preparation of the intermediate of formula Ila
wherein A and Q are as defined for formula I, uses the compound of formula VII Q-OH (VII), which is caused to react with a compound of formula Xlllai, XIIIa
2, XIIIa , Xffl^ or XIIIa
5
under typical base-catalysed reaction conditions of alkylation or etherification, as described in detail hereinbefore for the preparation of the compound of formula I, the radicals Q and R131 to Rι40 in the compounds of formulae VII and XHIaj to Xlllas being as defined for formula I and L being a leaving group such as, for example, halogen, e.g. chlorine, bromine or iodine, acetate or sulfonate, e.g. mesylate or tosylate.
The process of the nucleophilic aromatic substitution reaction described in detail hereinbefore for the preparation of compounds of formula I is also suitable for the preparation of the intermediates of formula Ila
wherein A and Q are as defined for formula I, by causing a compound of formula VIIi
to react with a compound of formula XlVaj , XIVa
2, XIVa
3, XIV a or XIV a
under typical reaction conditions of nucleophilic aromatic substitution, the radicals Q and Ri3i to Rι40 in the compounds of formulae VIIi and XlVai to XTVas being as defined for formula I, Li being a leaving group such as, for example, halogen, e.g. fluorine (for Q = Q2 to Q8), chlorine, bromine or iodine, or a sulfonate, e.g. -OTosyl (-OTs) or -OMesyl (-OMs), an alkylsulfonyl (for Q = Q2 to Q8), e.g. CH3SO2-, imidazolyl, triazolyl, -SCH3 or phenoxy, and M+ being an alkali metal ion, e.g. Na+.
The intermediate of formula XV
wherein A and Q are as defined for formula I and E is an electrophilic functional group
whereinRι
4ι is as defined for formula I, R
]49 is hydrogen, C
1-C
4alkyl, Cι-C
6haloalkyl, C
2-C
6alkenyl, C
2-C
6haloalkenyl, C -C
6alkynyl, C
2-C
6hydroxyalkyl, Cj-C
6alkoxy- C]-C
6alkyl, phenyl or benzyl, wherein the two phenyl rings may be substituted from one to five times by substituents selected from halogen and Cι-C
6alkyl and/or once, twice or three times by substituents selected from Cι-C
6haloalkyl, -OH, Cι-C
6alkoxy,
Cι-C
6haloalkoxy and -COR
227, wherein R
227 is as defined for formula I, and Xi is a leaving group such as, for example, halogen, e.g. fluorine, chlorine, bromine or iodine, or a sulfonate, e.g. -OTosyl (-OTs), -OMesyl (-OMs) or -OTriflate (-OTf), CH
3(CH
3O)N-, imidazolyl, triazolyl, -OR
4, -SR) or -N(R
4)
2, wherein R is Cι-C
6alkyl, d-C
6haloalkyl or phenyl, may be obtained by means of the Mitsunobu reaction (Reaction Scheme 1) from a compound of formula VII Q-OH (VII) and a compound of formula XVI
the radicals A, Q and E in the compounds of formulae VII and XVI being as defined.
The intermediate of formula XV
wherein A and Q are as defined for formula I and E is an electrophilic functional group
wherein R
141 is as defined for formula I, R
149 is hydrogen, Cι-C
4alkyl, Cι-C
6haloalkyl, C
2-C
6alkenyl, C
2-C
6haloalkenyl, C
2-C
6alkynyl, C
2-C
6hydroxyalkyl, Cι-C
6alkoxy- Cι-C
6alkyl, phenyl or benzyl, wherein the two phenyl rings may be substituted from one to five times by substituents selected from halogen and d-C
6alkyl and/or once, twice or three times by substituents selected from Cι-C
6haloalkyl, -OH, Cpdalkoxy,
Cι-C6haloalkoxy and -COR227, wherein R227 is as defined for formula I, and Xi is a leaving group such as, for example, halogen, e.g. fluorine, chlorine, bromine or iodine, or a sulfonate, e.g. -OTosyl (-OTs), -OMesyl (-OMs) or -OTriflate (-OTf), CH3(CH3O)N-,
imidazolyl, triazolyl, -OR*, -SR4 or -N(R4)2, wherein R4 is Cι-C6alkyl, Cι-C6haloalkyl or phenyl, may also be prepared by means of base-catalysed alkylation or etherification of a compound of formula VII Q-OH (VII) with a compound of formula XVIIai, XVIIa2, XVIIa , XVI^ or XVIIa5
the radicals Q and E in the compounds of formulae VII and XVIIaj to XVIIa5 being as defined, R131 to Rι40 being as defined for formula I and L being a leaving group such as, for example, halogen, e.g. chlorine, bromine or iodine, acetate or sulfonate, e.g. mesylate (-OMs) or tosylate (-OTs).
A further possible method of preparing the desired intermediates of formula XV
wherein A and Q are as defined for formula I and E is an electrophilic functional group as already defined hereinbefore, is provided by the reaction of the compound of formula VIIi
with a compound of formula XVIIIai, XVIIIa
2, XVIIIa
3, XVIIIa
4 or XVIIIa
5
under the above-described reaction conditions of the nucleophilic aromatic substitution reaction, the radicals Q and Rj31 to Rι40 in the compounds of formulae VIIi and XVIIIai to XVIIIa5 being as defined for formula I and E being an electrophilic functional group
wherein Rι
4] is as defined for formula I, R]
49 is hydrogen, d-C
4alkyl, Cι-C
6haloalkyl, C
2-C
6alkenyl, C
2-C
6haloalkenyl, C
2-C
6alkynyl, C
2-C
6hydroxyalkyl, Cι-C
6alkoxy- Cι-C
6alkyl, phenyl or benzyl, wherein the two phenyl rings may be substituted from one to five times by substituents selected from halogen and Cι-C
6alkyl and/or once, twice or
three times by substituents selected from C C
6haloalkyl, -OH, Cι-C
6alkoxy, Cι-C
6haloalkoxy and -COR
227, wherein R
227 is as defined for formula I, Li is a leaving group such as, for example, halogen, e.g. fluorine (for Q = Q
2 to Q
8), chlorine, bromine or iodine, or a sulfonate, e.g. -OTs or -OMs, an alkylsulfonyl (for Q = Q
2 to Q
8), e.g. CH
3SO
2-, imidazolyl, triazolyl, -SCH
3 or phenoxy, and M
+ is an alkali metal ion, e.g. Na
+.
The intermediates of formula XlXaibo, XIXa2bo, XLXa3bo, XIXa b0 or XIXa5bo
(XIXa4b0) or
wherein R
2, m and R
13ι to Rι
40 are as defined for formula I and R
3 is hydrogen or a protecting group for the alcohol function such as, for example, methoxymethyl (MOM), benzyl, benzoyl, acetyl, allyl, tetrahydropyranyl, tert-butyloxycarbonyl (BOC), benzyloxycarbonyl, trialkylsilyl, phenyl-dialkylsilyl or di-phenyl-alkylsilyl (T. W. Greene and P. G. M. Wuts, Protective Groups in Organic Chemistry, Wiley 1999), may be prepared, for example, by coupling a compound of formula XXai, XXa , XXa
3, XXa
4 or XXa
5
wherein R
3 and Rι
3ι to R
1 0 are as defined, with a compound of formula III
wherein R
2 and m are as defined and W is a leaving group such as, for example, halogen or trifluoromethanesulfonate (-OTf), in the presence of a palladium catalyst under Sonogashira reaction conditions (Reaction Scheme 1). The Sonogashira reaction has already been described in detail hereinbefore.
The intermediates of formula XXIa3b, XXIa b or XXIa5b
wherein B, R
2, m and R1
31 to Rι
36 are as defined for formula I, R
3 is hydrogen or a protecting group for the alcohol function as defined hereinbefore and E
4 is a bridging
member
wherein Rι
33 and Rι
35 to R]
40 are as defined for formula I, maybe prepared, for example, by causing a compound of formula XXIIa
3, XXIIa
4 or XXIIa
5
(XXIIa
5),
wherein R
131 to Rι
40 and R
3 are as defined, to react with a compound of formula lib
wherein B, R and m are as defined, in the presence a) of a strong base or b) of zinc salts and a base in an inert organic solvent at temperatures from -100° to 50°C. That reaction has also been described in detail hereinbefore.
The intermediates of formula XXOIabi, XXIIIab2, XXIIIab3 or XXIIIab4
XIIIab ),
(XXIIIab3) or
(XXIIIabΛ
wherein A, R
2, m and Rι
43 to Rι
8 are as defined for formula I, it being possible for the alcohol function in group A to be protected by a protecting group for alcohols such as, for example, MOM, benzyl, benzoyl, acetyl, allyl, tetrahydropyranyl, tert- butyloxycarbonyl (BOC), benzyloxycarbonyl, trialkylsilyl, phenyl-dialkylsilyl or di- phenyl-alkylsilyl, and E] is a bridging member
wherein R
141 is as defined for formula I and Rι
4 is hydrogen, Cι-C
4alkyl, Cι-C
6haloalkyl, C
2-C
6alkenyl, C -C
6haloalkenyl, C
2-C
6alkynyl, C -C
6hydroxyalkyl, Cι-C
6alkoxy-Cι-C
6alkyl, phenyl or benzyl, wherein the two phenyl rings may be substituted from one to five times by substituents selected from halogen and Cι-C
6alkyl and/or once, twice or three times by substituents selected from Cι-C
6haloalkyl, -OH, Cι-C
6alkoxy, Cι-C
6haloalkoxy and -COR
227, wherein R
227 is as defined for formula I, may be prepared by causing a compound of formula XII
HA — C=CH (XII), wherein A is as defined, to react with a compound of formula IVbi, IVb2, IVb3 or IVb4
wherein R2, m and Rι43 to Rj48 are as defined and E is an electrophilic functional group
wherein Rj
4ι and Rι
49 are as defined and Xi is a leaving group such as, for example, halogen, e.g. fluorine, chlorine, bromine or iodine, or a sulfonate, e.g. -OTosyl (-OTs), -OMesyl (-OMs) or triflate (-OTf), CH
3(CH
30)N-, imidazolyl, triazolyl, -OR^ -SR
4 or -N(R
4)
2, wherein R
4 is Cι-C
6alkyl, Cι-C
6haloalkyl or phenyl, in the presence a) of a strong base or b) of zinc salts and a base
in an inert, organic solvent at temperatures from -100° to 50°C, it being possible for the alcohol-protecting group to be removed and for the exposed hydroxyl function to be used for further reactions, e.g. nucleophilic aromatic substitution.
The intermediates of formula XXVa2b, XXVa3b, XXVjub or XXVa5b
wherein R
2, B, Rι
3ι to Rι
38 and m are as defined for formula I, R
3 is hydrogen or a protecting group for the alcohol function, e.g. MOM, benzyl, benzόyl, acetyl, allyl, tetrahydropyranyl, BOC or benzyloxycarbonyl, and E
3 is a bridging member
,149 wherein Rι
33, Rι
35, Rι
37 and R
]39 are as defined for formula I and Rι
49 is hydrogen, Cι-C alkyl, Cι-C
6haloalkyl, C
2-C
6alkenyl, C
2-C
6haloalkenyl, C
2-C
6alkynyl, C
2-C
6hydroxyalkyl, Cι-C6alkoxy-Cι-C
6alkyl, phenyl or benzyl, wherein the two phenyl
rings may be substituted from one to five times by substituents selected from halogen and Cι-C
6alkyl and/or once, twice or three times by substituents selected from Cι-C
6haloalkyl, -OH, d-C
6alkoxy, Cι-C
6haloalkoxy and -COR
227, wherein R
227 is as defined for formula I, may be prepared by causing a compound of formula lib
wherein R
2, B and m are as defined, to react with a compound of formula XXIVa , XXIVa
3, XXIVa
4 or XXIVa
5 (XXIVa
3),
R, (XXIVa
5),
wherein R
3 and R
131 to Rι
38 are as defined and E is an electrophilic functional group
wherein Rι
33, Rj
5, Rι
37, Rι
39 and Rι
9 are as defined and
'Xj is a leaving group such as, for example, halogen, e.g. fluorine, chlorine, bromine or iodine, or sulfonate, e.g. para- toluenesulfonate (-OTs, tosylate), methanesulfonate (-OMs, mesylate) or trifluoromethanesulfonate (-OTf, triflate), or CH
3(CH
30)N-, imidazolyl, triazolyl, -OR
4, -SR
t or -N(R
4)
2, wherein R
4 is Cι-C
6alkyl, Cι-C
6haloalkyl or phenyl, in the presence
a) of a strong base or b) of zinc salts and a base in an inert, organic solvent at temperatures from -100° to 50°C.
The intermediates of formula XXIIIab2, XXIIIab3 or XXIIIab4
(XXIHab
4),
wherein A, R
2, Rι
45 to Rj
8 and m are as defined for formula I, it being possible for the alcohol function in group A to be protected by a protecting group for alcohols such as, for example, MOM, benzyl, benzoyl, acetyl, allyl, tetrahydropyranyl, tert- butyloxycarbonyl (BOC), benzyloxycarbonyl, trialkylsilyl, phenyl-dialkylsilyl or di-
R 141/ R142 phenyl-alkylsilyl, and E
2 is a bridging member __V , wherein R
141, Rj
42 and \ _
R143 OH
Rι
43 are as defined for formula I, may be prepared by causing a compound of formula XII HA — C≡CH (XII), wherein A is as defined, to react with a compound of formula Vb
2, Vb
3 or Vb
4
wherein R , m, Rj
4ι to Rι
3, and Rι
45 to R]
8 are as defined, in the presence a) of a strong base or b) of zinc salts and a base in an inert, organic solvent at temperatures from -100° to 50°C, it being possible for the alcohol-protecting group to be removed by means of suitable treatment and for the exposed hydroxyl function to be used for further reactions.
The intermediates of formula XXVa3b, XXVa4b or XXVa5b
wherein R
2, B, Rι
31 to Rι
36 and m are as defined for formula I, R
3 is hydrogen or a protecting group for the alcohol function such as, for example, MOM, benzyl, benzoyl, acetyl, allyl, tetrahydropyranyl, tert-butyloxycarbonyl (BOC), benzyloxycarbonyl, trialkylsilyl, phenyl-dialkylsilyl or di-phenyl-alkylsilyl, and E
4 is a bridging member
O.H R 133 OH
R135 OH
/R \ / \ or A / \ 135
R136
R137
R 138
R139 140 wherein Rι
33 and Rι
35 to Rι
0 are as defined for formula I, may be prepared by causing a compound of formula lib
wherein R
2, B and m are as defined, to react with a compound of formula XXIIa
3, XXIL^ or XXIIa
5
(XXIIa4) or
wherein R
131 to Rι
40 and R
3 are as defined, in the presence a) of a strong base or b) of zinc salts and a base in an inert, organic solvent at temperatures from -100° to 50°C.
The following applies to the individual reaction steps:
The reactions resulting in the compounds of formula I, Iabo, Iabi to Iab4 or Ia2b to Ia5b are advantageously carried out in aprotic, inert solvents. Such solvents are hydrocarbons, e.g. benzene, toluene, xylene or cyclohexane, chlorinated hydrocarbons, e.g. dichloromethane, trichloromethane, tetrachloromethane or chlorobenzene, ethers, e.g. diethyl ether, ethylene glycol dimethyl ether, diethylene glycol dimethyl ether, tetrahydrofuran or dioxane, nitriles, e.g. acetonitrile or propionitrile, and amides, e.g. N,N-dimethylformamide, diethylformamide or N-methylpyrrolidinone. The reaction temperatures are preferably from -20°C to +120°C. The reactions are generally slightly
exothermic and may usually be carried out at room temperature. In order to shorten the reaction time or else to initiate the reaction, brief heating up to the boiling point of the reaction mixture may be carried out, where appropriate. The reaction times may also be reduced by adding a few drops of base as reaction catalyst. Especially suitable bases are tertiary amines, e.g. trimethylamine, triethylamine, quinuclidine, 1,4- diazabicyclo[2.2.2]octane, l,5-diazabicyclo[4.3.0]non-5-ene or l,5-diazabicyclo[5.4.0]- Undec-7-ene. It is, however, also possible for inorganic bases such as hydrides, e.g. sodium or calcium hydride, hydroxides, e.g. sodium or potassium hydroxide, carbonates, e.g. sodium or potassium carbonate, or hydrogen carbonates, e.g. potassium or sodium hydrogen carbonate, to be used as bases.
The compounds of formula I, Iab0, Iabi to Iab4 or Ia2b to Ia5b may be isolated in conventional manner by concentration and/or evaporation of the solvent and purified by recrystallisation or trituration of the solid residue in solvents in which they are not readily soluble, such as ethers, aromatic hydrocarbons or chlorinated hydrocarbons.
The starting compounds of formulae lib, III, IVbi to TVb , Vb2 to Vb4, Vlai to VIa4, VIIi, VIII, IXaj to IXa5, Xai to Xa5, XIa3 to XIa5, Xlllai to XIIIa5, XlVai to XrVa5, XVI, XVIIaj to XVIIa5, XVIIIai to XVIIIa5, XXaj to XXa5, XXIIa3 to XXIIa5 and XXIVa2 to XXrVa5 used for preparation of the compounds of formula I, Iab0, Iabi to Iab or Ia b to Ia5b are for the most part known or they may be prepared in analogy to known methods. The starting compounds of formulae VII and XII are likewise known and in some cases are commercially available, or they can be prepared in analogy to known methods.
For the use according to the invention of the compounds of formula I, or of compositions comprising them, there come into consideration all methods of application customary in agriculture, for example pre-emergence application, post-emergence application and seed dressing, and also various methods and techniques such as, for example, the controlled release of active ingredient. For that purpose a solution of the active ingredient is applied to mineral granule carriers or polymerised granules (urea/formaldehyde) and dried. If required, it is also possible to apply a coating (coated granules), which allows the active ingredient to be released in metered amounts over a specific period of time.
The compounds of formula I may be used as herbicides in their unmodified form, that is to say as obtained in the synthesis, but they are preferably foπnulated in customary manner together with the adjuvants conventionally employed in formulation technology, for example into emulsifiable concentrates, directly sprayable or dilutable solutions, dilute emulsions, wettable powders, soluble powders, dusts, granules or microcapsules. Such formulations are described, for example, on pages 9 to 13 of WO 97/34485. As with the nature of the compositions, the methods of application, such as spraying, atomising, dusting, wetting, scattering or pouring, are chosen in accordance with the intended objectives and the prevailing circumstances.
The formulations, that is to say the compositions, preparations or mixtures comprising the compound (active ingredient) of formula I, or at least one compound of formula I, and, usually, one or more solid or liquid formulation adjuvants, are prepared in known manner, e.g. by homogeneously mixing and/or grinding the active ingredient(s) with the formulation adjuvants, for example solvents or solid carriers. Surface-active compounds (surfactants) may also be used in addition in the preparation of the formulations. Examples of solvents and solid carriers are given, for example, on page 6 of WO 97/34485.
Depending upon the nature of the compound of formula I to be formulated, suitable surface-active compounds are non-ionic, cationic and/or anionic surfactants and surfactant mixtures having good emulsifying, dispersing and wetting properties. Examples of suitable anionic, non-ionic and cationic surfactants are listed, for example, on pages 7 and 8 of WO 97/34485. In addition, the surfactants conventionally employed in formulation technology, which are described, ter alia, in "McCutcheon's Detergents and Emulsifiers Annual" MC Publishing Corp., Ridgewood New Jersey, 1981, Stache, H., "Tensid-Taschenbuch", Carl Hanser Verlag, Munich/Vienna, 1981, and M. and J. Ash, "Encyclopedia of Surfactants", Vol. I- III, Chemical Publishing Co., New York, 1980-81, are also suitable for the preparation of the herbicidal compositions according to the invention.
The herbicidal formulations generally contain from 0.1 to 99 % by weight, especially from 0.1 to 95 % by weight, of herbicide, from 1 to 99.9 % by weight, especially from 5
to 99.8 % by weight, of a solid or liquid formulation adjuvant, and from 0 to 25 % by weight, especially from 0.1 to 25 % by weight, of a surfactant. Whereas commercial products will preferably be in the form of concentrates, the end user will normally employ dilute formulations. The compositions may also comprise further ingredients, such as stabilisers, for example vegetable oils or epoxidised vegetable oils (epoxidised coconut oil, rapeseed oil or soybean oil), anti-foams, for example silicone oil, preservatives, viscosity regulators, binders, tackifiers, and also fertilisers or other active ingredients.
The compounds of formula I are generally applied to the plant or the locus thereof at rates of application of from 0.001 to 4 kg/ha, especially from 0.005 to 2 kg/ha. The concentration required to achieve the desired effect can be determined by experiment. It is dependent on the nature of the action, the stage of development of the cultivated plant and of the weed and on the application (place, time, method) and may vary within wide limits as a function of those parameters.
The compounds of formula I are distinguished by herbicidal and growth-inhibiting properties, allowing them to be used in crops of useful plants, especially cereals, cotton, soybeans, sugar beet, sugar cane, plantation crops, rape, maize and rice, and also for non- selective weed control. The term "crops" is to be understood as including also crops that have been made tolerant to herbicides or classes of herbicides as a result of conventional methods of breeding or genetic engineering techniques. The weeds to be controlled may be either monocotyledonous or dicotyledonous weeds, such as, for example, Stellaria, Nasturtium, Agrostis, Digitaria, Avena, Setaria, Panicum, Sinapis, Lolium, Solanum, Echinochloa, Scirpus, Euphorbia, Monochoria, Sagittaria, Bromus, Alopecurus, Sorghum halepense, Rottboellia, Cyperus, Abutilon, Sida, Xanthium, Amaranthus, Chenopodium, Ipomoea, Chrysanthemum, Galium, Viola and Veronica.
The following Examples further illustrate the invention.
Preparation Examples:
Example PI : Preparation of 4-(4-fluoro-2-methoxy-phenoxyVl-(3-chlorophenyl)-l- hydroxy-but-2-yήe
7.11 g (39.46 mmol) of 4-fluoro-2-methoxy-0-propargyl-phenol ether are dissolved in 70 ml of THF. 43.4 ml of lithium bis(trimethylsilyl)amide (1.1 equivalents) in hexane (IM solution) are then added dropwise at -65° to -70°C over the course of 10 minutes and stirring is carried out for a further 30 minutes at -70°C. With the aid of a syringe, 6.29 ml of 3-chlorobenzaldehyde (1.1 equivalents) are slowly added at -63°C and further stirring is carried out while the coolant becomes warmer. After 4 hours, aqueous ammonium chloride solution is added to the reaction mixture at -45 °C and the resulting mixture is partitioned between diethyl ether and ice-water. The organic phase that is separated off is washed with dilute brine solution and dried over sodium sulfate. After filtering, concentration under reduced pressure is carried out and the resulting residue is subjected to flash chromatography on a silica gel column (eluant: ethyl acetate/hexane 1/3). The desired title compound is obtained in a yield of 7.88 g (62.3 % of theory) in the form of brown-yellow crystals.
Example P2: Preparation of 4-(,4-fluoro-2-methoxy-phenoxy)-l-(3-chlorophenyl -l- fluoro-but-2-yne
0.59 g (1.839 mmol) of 4-(4-fluoro-2-methoxy-phenoxy)-l-(3-chlorophenyl)-l-hydroxy- but-2-yne (Example PI) is dissolved in 15 ml of dichloromethane and, at -65° to -70°C, 0.30 ml of diethylaminosulfur trifluoride ((C2H5)2NSF3, DAST, 95 %) is added. The reaction mixture is stirred for a further 45 minutes at -70°C, then ice-water is added and extraction with diethyl ether is carried out. The organic phase that is separated off is washed with dilute brine solution and dried over sodium sulfate; the desiccant is filtered
off and the solvent is evaporated off under reduced pressure. The residue obtained is subjected to flash chromatography (eluant: ethyl acetate/hexane 1/8). The desired title compound is obtained in a yield of 0.12 g (20.3 % of theory) in the form of a yellow oil.
Example P3: Preparation of 4-(4-fluoro-2-methoxy-phenoxy -l-(3-phenyl-acetonitrile)- but-1-yne
Compound no. 1.013 509.2 mg (2.1 mmol) of 3-iodo-l-phenylacetonitrile are introduced into piperidine under an argon atmosphere and stirred for 30 minutes. Then 117.95 mg (0.102 mmol) of tetrakis(triphenylphosphine)palladium (Pd[(C
6H
5)
3P] ) are added and stirred for 1 hour until a clear solution is formed. Then 400 mg (2.083 mmol) of 4-fluoro-2-methoxy-0-4- (but-l-ynyl)-phenol ether (Example P4) are dissolved in piperidine and, immediately afterwards, 34.10 mg (0.179 mmol) of copper(I) iodide are added in one portion. Stirring is carried out for a further 2.5 hours at 25°C. The reaction mixture is poured into 150 ml of ammonium chloride solution, stirred well and extracted three times with diethyl ether. The combined organic phases are washed with 2 portions each of ammonium chloride solution, water and brine and concentrated by evaporation under reduced pressure. The yellow-brown oil obtained is purified by silica gel chromatography (eluant: ethyl acetate/hexane 1/4). The desired target compound is obtained in the form of a yellow powder in a yield of 230 mg (35.7 % of theory) with a melting point of 69-71°C.
Example P4: Preparation of 4-fluoro-2-methoxy-0-4-(but-l-vnyl)-phenol ether
1.5 g (10.56 mmol) of 4-fluoro-2-methoxyphenol are introduced into 120 ml of dichloromethane and there are then added, with stirring, 4.5 g and 9.0 g (37.56 mmol) of polymer-bound triphenylphosphine (polymer-C6H P(C6H5)2, on copolymer of 98 % styrene and 2 % divinylbenzene) in 2 portions and then 1.4718 g (21 mmol) of 3-butyn-
l-ol dissolved in a small amount of dichloromethane. Then 7.267 g (31.56 mmol) of azodicarboxylic acid diethyl ester (DEAD) are added in portions and the brown reaction mixture is stirred overnight at 25 °C. GC analysis shows a conversion of more than 66 %. For working up, 60 ml of trifluoroacetic acid are added to the reaction mixture and the mixture is stirred at 25°C for 1.5 hours. The reaction mixture is poured into 300 ml of ammonium chloride solution, stirred well and extracted three times with diethyl ether. The combined organic phases are washed with 2 portions each of ammonium chloride solution, water and brine and concentrated by evaporation under reduced pressure. The desired title compound is obtained in the form of a viscous oil in a crude yield of 810 mg (40 % of theory).
Example P5: Preparation of 5-("4-fluoro-2-methoxy-phenoxy -l-(3-phenylacetonitrile)- pent-1-vne
500 mg (3.52 mmol) of 4-fluoro-2-methoxyphenol are introduced into 40 ml of dichloromethane under a nitrogen atmosphere at 25°C and 300 mg (9.0 mmol) of polymer-bound triphenylphosphine are added. Then 1393 mg (7.0 mmol) of 5-(3-phenylacetonitrile)- pent-4-yn-l-ol (Example P6) dissolved in a small amount of dichloromethane are slowly added dropwise; then 1612 mg (7.0 mmol) of DEAD are added in portions and that reaction mixture is stirred overnight at 25°C. For working up of the reaction mixture, 20 ml of trifluoroacetic acid are added to the mixture, which is stirred for 1.5 hours at 25 °C. The reaction mixture is poured into 150 ml of ammonium chloride solution, stirred well and extracted three times with diethyl ether. The combined organic phases are washed with 2 portions each of ammonium chloride solution, water and brine and concentrated by evaporation under reduced pressure. The target compound is obtained in the form of a brown oil in a crude yield of 1.67 g. Purification by means of HPLC column chromatography (eluant: ethyl acetate/hexane 1/3 and ethyl acetate as gradient mobile phase over 14 minutes) yields 370 mg of the desired target compound in the form of a yellow oil.
Example P6: Preparation of 5-(3-phenylacetonitrile)-pent-4-yn-l-ol
To a solvent mixture of 75 ml of toluene and 150 ml of n-butylamine under a nitrogen atmosphere there are added first 9.80 g (0.05 mol) of 3-bromo-phenylacetonitrile and then 701.9 mg (0.001 mol) of bis(triphenylphosphine)palladium dichloride
(PdCl2(PPh3)2) and 190.44 mg (0.001 mol) of copper(I) iodide at 20°C. Then, at 20°C, 8.42 g (0.10 mol) of 4-pentyn-l-ol, dissolved in a toluene/n-butylamine mixture, are slowly added dropwise, whereupon a yellow-brown clear solution is formed, which is heated at 100°C for 5 hours, with stirring. The reaction mixture is then concentrated completely under reduced pressure, the residue obtained is stirred in a mixture of 100 ml each of ethyl acetate and of water and the two phase-separated solvents are separated off from one another. The aqueous phase is extracted three times with ethyl acetate and the combined organic phases are dried over magnesium sulfate, filtered and concentrated by evaporation in vacuo. A brown oil is obtained in a crude yield of 14.01 g, which is purified by means of column chromatography (eluant: ethyl acetate/hexane 1/4 to 1/1 as gradient mobile phase). The desired title compound is obtained in the form of a brown oil in a yield of 5.95 g.
Example P7: Preparation of l-chloro-4-(4-chlorophenyl -but-3-yn-2-one (Helv. Chim. Acta 85, 3052-3077 (2002) + CI-C-CH
2CI -*"
To 1.26 g (1.3 equivalents) of aluminium trichloride (A1C13), for the most part dissolved in 20 ml of dichloromethane there are added dropwise, at -10°C, with cooling in an ice/ethanol mixture, a solution of 1.50 g (1 equivalent, 7.185 mmol) of l-(4- chlorophenyl)-2-(trimethylsilyl)acetylene, 0.58 ml (1 equivalent) of chloroacetyl chloride and 10 ml of dichloromethane over 20 minutes, the reaction mixture becoming a violet- brown colour. Further stirring is then carried out while the coolant mixture slowly warms up to -2°C (internal temperature), that is to say until TLC monitoring indicates that conversion is complete (about 45 minutes). Then the reaction mixture, having warmed up
to — 2°C, is cautiously quenched by adding small pieces of ice, and partitioning between diethyl ether and aqueous solution is carried out. The separated organic phase is washed with brine and dried over sodium sulfate. After evaporating off the solvent under reduced pressure, 2.97 g of a solid brown residue are obtained. Purification of that residue is carried out by means of silica gel chromatography (eluant: ethyl acetate/hexane 1:10). The desired title compound is obtained in a yield of 1.1 g (71.9 % of theory) in the form of a yellow-brown solid having a purity of > 95 %.
Example P8: Preparation of 4-(4-fluoro-2-methoxy-phenoxy -l-(3- cyanomethylphenyl)but-2-yn- 1 -one (compound no. 3.075)
To a solution of 0.32 g (0.915 mmol) of 4-(4-fluoro-2-methoxy-phenoxy)-l-(3-_ cyanomethylphenyl)-l-hydroxy-but-2-yne (compound no. 3.089) in 15 ml of ethyl acetate there is added 0.77 g (3 equivalents) of o-iodoxybenzoic acid (IBX; see Organic Letters 4(17), 3001-3003 (2002)) and stirring is carried out for 3.5 hours at 90°C. TLC monitoring shows conversion is complete. The reaction mixture is cooled in an ice bath and the precipitated solid is filtered off. The filtrate is washed with dilute sodium hydrogen carbonate solution and then with brine, dried over sodium sulfate and concentrated under reduced pressure. 0.31 g of a brown- yellow resin is obtained as the crude product, which is purified by means of silica gel chromatography (eluant: ethyl acetate/hexane 1/4). 0.20 g (67.6 % of theory) of the desired title compound is obtained in the form of a yellow oil. MS (ESI): m/z = 322 [M-H]'.
It is also possible for the preferred compounds listed in the following Tables to be obtained in a manner analogous to that described in Examples PI to P8 or by the methods described in the references indicated. In the Table A the compounds prepared from Table 1-3 are compiled with physico-chemical data and technical aspects, respectively.
Table 1: Compounds of formula Ia2b0Qι:
Cmp. R Ri R2 Rl31 R132 R133 R134 no.
1.001 CH3 H (n=0) H (m=0) H H H H
1.002 CH3 4-F H (m=0) H H H H
1.003 CH3 4-Cl H (m=0) H H H H
1.004 CH3 4-Br H (m=0) H H H H
1.005 CH3 4-1 H (m=0) H H H H
1.006 CH3 4-CF3 H (m=0) H H H H
1.007 CH3 4-CN H (m=0) H H H H
1.008 CH3 4-CHO H (m=0) H H H H
1.009 CH3 4-CH=NOCH3 H (m-0) H H H H
1.010 CH3 4-CH3 H (m=0) H H H H
1.011 CH3 4-CH=CCl2 H (m=0) H H H H
1.012 CH3 H (n=0) 3-CH2CN H H H H
1.013 CH3 4-F 3-CH2CN H H H H
1.014 CH3 4-Cl 3-CH2CN H H H H
1.015 CH3 4-Br 3-CH2CN H H H H
1.016 CH3 4-1 3-CH2CN H H H H
1.017 CH3 4-CF3 3-CH2CN H H H H
1.018 CH3 4-CN 3-CH2CN H H H H
1.019 CH3 4-CHO 3-CH2CN H H H H
Cmp. R Ri R2 Rl31 Rl32 Rl33 R134 no.
1.020 CH3 4-CH=NOCH3 3-CH2CN H H H H
1.021 CH3 4-CH3 3-CH2CN H H H H
1.022 CH3 4-CH=CCl2 3-CH2CN H H H H
1.023 CH3 H (n=0) 3-CH2CN, 4-F H H H H
1.024 CH3 4-F 3-CH2CN, 4-F H H H H
1.025 CH3 4-Br 3-CH2CN, 4-F H H H H
1.026 CH3 4-CN 3-CH2CN, 4-F H H H H
1.027 CH3 4-CF3 3-CH2CN, 4-F H H H H
1.028 CH3 4-CH=NOCH3 3-CH2CN, 4-F H H H H
1.029 CH3 H (n=0) ' 3-'CH2CN, 6-F H H H H
1.030 CH3 4-F 3-CH2CN, 6-F H H H H
1.031 CH3 4-Br 3-CH2CN, 6-F H H H H
1.032 CH3 4-CN 3-CH2CN, 6-F H H . H H
1.033 CH3 4-CF3 3-CH2CN, 6-F H H H H
1.034 CH3 4-CH=NOCH3 ' 3-CH2CN, 6-F H H H H
1.035 CH3 H (n=0) 3-CH2CN, 4-F, 6-F H H H H
1.036 CH3 4-F 3-CH2CN, 4-F, 6-F H H H H
1.037 CH3 4-Br .3-CH2CN, 4-F, 6-F H H H H
1.038 CH3 4-CN 3-CH2CN, 4-F, 6-F H H H H
1.039 CH3 4-CF3 3-CH2CN, 4-F, 6-F H H H H
1.040 CH3 4-CH=NOCH3 3-CH2CN, 4-F, 6-F H H H H
1.041 CH3 4-F 3-CH2CN, 4-Cl, 6-F H H H H
1.042 CH3 4-1 3-CH2CN, 4-Cl, 6-F H H H H
1.043 CH3 4-CN 3-CH2CN, 4-Cl, 6-F H H H H
1.044 CH3 4-CF3 3-CH2CN, 4-Cl, 6-F H H H H
1.045 CH3 4-CH=NOCH3 3-CH2CN, 4-Cl, 6-F H H H H
1.046 CH3 H (n=0) 3-CH(CH3)CN H H H H
1.047 CH3 4-F 3-CH(CH3)CN H H H H
1.048 CH3 4-Cl 3-CH(CH3)CN H H H H
1.049 CH3 4-Br 3-CH(CH3)CN H H H H
Cmp. R Ri R2 R131 Rl32 R133 R134 no.
1.050 CH3 4-1 3-CH(CH3)CN H H H H
1.051 CH3 4-CF3 3-CH(CH3)CN H H H H
1.052 CH3 4-CN 3-CH(CH3)CN H H H H
1.053 CH3 4-CHO 3-CH(CH3)CN H H H H
1.054 CH3 4-CH=NOCH3 3-CH(CH3)CN H H H H
1.055 CH3 4-CH3 3-CH(CH3)CN H H H H
1.056 CH3 4-CH=CCl2 3-CH(CH3)CN H H H H
1.057 CH3 H (n=0) 3-CHF2 H H H H
1.058 CH3 4-F 3-CHF2 H H H H
1.059 CH3 4-Cl 3-CHF2 H H H H
1.060 CH3 4-Br 3-CHF2 H H H H
1.061 CH3 4-1 3-CHF2 H H H H
1.062 CH3 4-CF3 3-CHF2 H H H H
1.063 CH3 4-CN 3-CHF2 H H H H
1.064 CH3 4-CHO 3-CHF2 H H H H
1.065 CH3 4-CH=NOCH3 3-CHF2 H H H H
1.066 CH3 4-CH3 3-CHF2 H H H H
1.067 CH3 4-CH=CCl2 3-CHF2 H H H H
1.068 CH3 H (n=0) 3-CHF2, 4-F . H H H H
1.069 CH3 4-F 3-CHF2, 4-F H H H H
1.070 CH3 4-Br 3-CHF2, 4-F H H H H
1.071 CH3 4-CN 3-CHF2, 4-F H H H H •
1.072 CH3 4-CF3 3-CHF2, 4-F H H H H
1.073 CH3 4-CH=NOCH3 3-CHF2, 4-F H H H H
1.074 CH3 H (n=0) 3-CH2CN H H =0
1.075 CH3 4-F 3-CH2CN H H -0
1.076 CH3 4-Br 3-CH2CN H H =0
1.077 CH3 4-CH3 3-CH2CN H H =0
1.078 CH3 4-CN 3-CH2CN H H =0
1.079 CH
3 4-CF
3 3-CH
2CN H H =0
Cmp. R Ri R
2 Rl31 Rl32 R133 134 no.
1.110 CH3 H (n=0) 3-CH2CN H H OCH3 H
1.111 CH3 4-F 3-CH2CN H H OCH3 H
1.112 CH3 4-Br 3-CH2CN H H OCH3 H
1.113 CH3 4-CH3 3-CH2CN H H OCH3 H
1.114 CH3 4-CN 3-CH2CN H H OCH3 H
1.115 CH3 4-CF3 3-CH2CN H H OCH3 H
1.116 CH3 4-CH=NOCH3 3-CH2CN H H OCH3 H
1.117 CH3 H (n=0) 3-CH2CN H H CH3 H
1.118 CH3 4-F 3-CH2CN H H CH3 H
1.119 CH3 4-Br 3-CH2CN H H CH3 H
1.120 CH3 4-CH3 3-CH2CN H H CH3 H
1.121 CH3 4-CN 3-CH2CN H H CH3 H
1.122 CH3 4-CF3 3-CH2CN H H CH3 H
1.123 CH3 4-CH=NOCH3 3-CH2CN H H CH3 H
1.124 CH3 H (n=0) 3-CH2CN H H CH3 CH3
1.125 CH3 4-F 3-CH2CN H H CH3 CH3
1.126 CH3 4-Br 3-CH2CN H H CH3 CH3
1.127 CH3 4-CH3 3-CH2CN H H CH3 CH3
1.128 CH3 4-CN 3-CH2CN H H CH3 CH3
1.129 CH3 4-CF3 3-CH2CN H H CH3 CH3
1.130 CH3 4-CH=NOCH3 3-CH2CN H H CH3 CH3
1.131 CH3 H (n=0) 3-CH2CN H H C2alkylene
1.132 CH3 4-F 3-CH2CN H H C2alkylene
1.133 CH3 4-Br 3-CH2CN H H C2alkylene
1.134 CH3 4-CH3 3-CH2CN H H C2alkylene
1.135 CH3 4-CN 3-CH2CN H H C2alkylene
1.136 CH3 4-CF3 3-CH2CN H H C2alkylene
1.137 CH3 4-CH=NOCH3 3-CH2CN H H C2alkylene
1.138 CH3 H (n=0) 3-CHF2 H H OH H
1.139 CH3 4-F 3-CHF2 H H OH H
Cmp. R Ri R2 Rl31 Rl32 Rl33 R134 no. 1.140 CH3 4-CN 3-CHF2 H H OH H
1.141 CH3 H (n=0) 3-CH(CH3)CN H H OH H-
1.142 CH3 4-F 3-CH(CH3)CN H H OH H
1.143 CH3 4-CN 3-CH(CH3)CN H H OH H
1.144 CH3 H (n=0) 3-CH2CN, 4-F H H OH H
1.145 CH3 4-F 3-CH2CN, 4-F H H OH H
1.146 CH3 4-CN 3-CH2CN, 4-F H H OH H
1.147 CH3 H (n=0) 3-CHF2 H H F H
1.148 CH3 4-F 3-CHF2 H H F H
1.149 CH3 4-CN 3-CHF2 H H F H
1.150 CH3 H (n=0) 3-CH(CH3)CN H H F H
1.151 CH3 4-F 3-CH(CH3)CN H H F H
1.152 CH3 4-CN 3-CH(CH3)CN H H F H
1.153 CH3 H (n=0) 3-CH2CN, 4-F H H F H
1.154 CH3 4-F 3-CH2CN, 4-F H H F H
1.155 CH3 4-CN 3-CH2CN, 4-F H H F H
1.156 CH3 H (n=0) 3-CHF2 H H F F
1.157 CH3 4-F 3-CHF2 H H F F
1.158 CH3 4-CN ' 3-CHF2 H H F F
1.159 CH3 H (n=0) 3-CH(CH3)CN H H F F
1.160 CH3 4-F 3-CH(CH3)CN H H F F
1.161 CH3 4-CN 3-CH(CH3)CN H H F F
1.162 CH3 4-CH=NOCH3 3-CH(CH3)CN H H F F
1.163 CH3 H (n=0) 3-CH2CN, 4-F H H F F
1.164 CH3 4-F 3-CH2CN, 4-F H H F F
1.165 CH3 4-CN 3-CH2CN; 4-F H H F F
1.166 CH3 H (n=0) 3-CHF2 H H CH3 F
1.167 CH3 4-F 3-CHF2 H H CH3 F
1.168 CH3 4-CN 3-CHF2 H H CH3 F CH3 H (n=0) 3-CH(CH3)CN H H CH3 F
1 169
Cmp. R Ri R2 Rl31 Rl32 R133 Rl34 no.
1.170 CH3 4-F 3-CH(CH3)CN H H CH3 F
1.171 CH3 4-CN 3-CH(CH3)CN H H CH3 F
1.172 CH3 4-CH=NOCH3 3-CH(CH3)CN H H CH3 F
1.173 CH3 H (n=0) 3-CH2CN, 4-F H H CH3 F
1.174 CH3 4-F 3-CH2CN, 4-F H H CH3 F
1.175 CH3 4-CN 3-CH2CN, 4-F H H CH3 F
1.176 CH3 H (n=0) 3-CHF2 H H CH3 CH3
1.177 CH3 4-F 3-CHF2 H H CH3 CH3
1.178 CH3 4-CN 3-CHF2 H H CH3 CH3
1.179 CH3 H (n=0) 3-CH(CH3)CN H H CH3 CH3
1.180 CH3 4-F 3-CH(CH3)CN H H CH3 CH3
1.181 CH3 4-CN 3-CH(CH3)CN H H CH3 CH3
1.182 CH3 H (n=0) 3-CH2CN, 4-F H H CH3 CH3
1.183 CH3 4-F 3-CH2CN, 4-F H H CH3 CH3
1.184 CH3 4-CN 3-CH2CN, 4-F H H CH3 CH3
1.185 CH3 H (n=0) 3-CHF2 H H OCH3 H
1.186 CH3 4-F 3-CHF2 H H OCH3 H
1.187 CH3 4-CN 3-CHF2 H H OCH3 H
1.188 CH3 H (n=0) 3-CH(CH3)CN H H OCH3 H
1.189 CH3 4-F 3-CH(CH3)CN H H OCH3 H
1.190 CH3 4-CN 3-CH(CH3)CN H H OCH3 H
1.191 CH3 H (n=0) 3-CH2CN, 4-F H H OCH3 H
1.192 CH3 4-F 3-CH2CN, 4-F H H OCH3 H
1.193 CH3 4-CN 3-CH2CN, 4-F H H OCH3 H
1.194 CH3 H (n=0) 3-CH2CN H CH3 H H
1.195 CH3 4-F 3-CH2CN H CH3 H H
1.196 CH3 4-Br 3-CH2CN H CH3 H H
1.197 CH3 4-CH3 3-CH2CN H CH3 H H
1.198 CH3 4-CN 3-CH2CN H CH3 H H
1.199 CH3 4-CF3 3-CH2CN H CH3 H H
Cmp. R Ri R2 R131 Rl32 Rl33 Rl34 no.
1.200 CH3 4-CH=NOCH3 3-CH2CN H CH3 H H
1.201 CH3 H (n=0) 3-CH2CN H CH3 CH3 H
1.202 CH3 4-F 3-CHaCN H CH3 CH3 H
1.203 CH3 4-Br 3-CH2CN H CH3 CH3 H
1.204 CH3 4-CH3 3-CH2CN H CH3 CH3 H
1.205 CK3 4-CN 3-CΗ2CΗ H CH3 CH3 H
1.206 CH3 4-CF3 3-CH2CN H CH3 CH3 H
1.207 CH3 4-CH=NOCH3 3-CH2CN H CH3 CH3 H
1.208 CH3 H (n=0) 3-CH2CN H CH3 CH3 CH3
1.209 CH3 4-F 3-CH2CN H CH3 CH3 CH3
1.210 CH3 4-Br 3-CH2CN H CH3 CH3 CH3
1.211 CH3 4-CH3 3-CH2CN H CH3 CH3 CH3
1.212 CH3 4-CN 3-CH2CN H CH3 CH3 CH3
1.213 CH3 4-CF3 3-CH2CN H CH3 CH3 CH3
1.214 CH3 4-CH=NOCH3 3-CH2CN H CH3 CH3 CH3
1.215 CH3 H (n=0) 3-CH2CN H CH3 F F
1.216 CH3 4-F 3-CH2CN H CH3 F F
1.217 CH3 4-Br 3-CH2CN H CH3 F F
1.218 CH3 4-CH3 3-CH2CN H CH3 F F
1.219 CH3 4-CN 3-CH2CN H CH3 F F
1.220 CH3 4-CF3 3-CH2CN H CH3 F F
1.221 CH3 4-CH=NOCH3 3-CH2CN H CH3 F F
1.222 CH3 H (n=0) 3-Cl H H H H
1.223 CH3 4-F 3-Cl H H H H
1.224 CH3 4-1 3-Cl H H H H
1.225 CH3 4-CF3 3-Cl H H H H
1.226 CH3 4-CN 3-Cl H H H H
1.227 CH3 4-CH3 3-Cl H H H H
1.228 CH3 H (n=0) 4-Cl H H H H
1.229 CH
3 4-F 4-Cl H H H H
Cmp. R Ri
' R
2 Rl31 Rl3
2 R133 R134 no. 1.260 H 4-CN 3-CH
2CN H H CH
3 H 1.261 CH
3 4-F 4-Cl H H -0 1.262 CH
3 4-F 3-CH
2OC(0)C(CH
3)
3 H H -0 1.263 CH
3 4-F 3-CH
2CN H H OCH
3 CH
3 1.264 CH
3 4-F 3-CH2CN H H H OC(0 )C(CH 3)3
Table 2: Compounds of formula Ia2bnQ2 : 4 3
Cmp. Ri R2 Rl31 Rl32 R133 R134 no.
2.001 H (n=0) ' H (m=0) H H H H
2.002 3-F H (m=0) H H H H
2.003 3-Cl H (m=0) H H ■ H H
2.004 3-F, 5-F H (m=0) H H H H
2.005 3-F, 5-C1 H (m=0) H H H H
2.006 3-CF3 H (m=0) H H H H
2.007 3-F, 5-CF3 H (m=0) H H H H
2.008 3-Cl, 5-CF3 H (m=0) H H H H
2.009 5-CN H (m=0) H H H H
Cmp. R, R2 Rl31 Rl32 R133 •R134 no.
2.010 3-F, 5-CN H (m=0) H H H H
2.011 3-OCH3 H (m=0) H H H H
2.012 3-OCH3, 5-F H (m=0) . H H H H
2.013 3-OCH3, 5-C1 H (m=0) H H H H
2.014 3-OCH3, 5-CF3 H (m=0) H H H H
2.015 3-OCH3, 5-CN H (m=0) H H H H
2.016 5-N02 . H (m=0) H H H H
2.017 3-Cl, 5-N02 H (m=0) H H H H
2.018 H (n-0) 3-CH2CN H H H H
2.019 3-F 3-CH2CN H H H H
2.020 3-Cl 3-CH2CN H H H H
2.021 3-F, 5-F 3-CH2CN H H H H
2.022 3-F, 5-C1 3-CH2CN H H H H
2.023 5-CF3 3-CH2CN H H H H
2.024 3-F, 5-CF3 3-CH2CN H H H H
2.025 3-Cl, 5-CF3 3-CH2CN H H H H
2.026 5-CN 3-CH2CN H H H H
2.027 3-F, 5-CN 3-CH2CN H H H H
2.028 3-OCH3 3-CH2CN H H H H
2.029 3-OCH3, 5-F 3-CH2CN H H H H
2.030 3-OCH3, 5-C1 3-CH2CN H H H H
2.031 3-OCH3, 5-CF3 3-CH2CN H H H H
2.032 3-OCH3, 5-CN 3-CH2CN H H H H
2.033 5-NO2 3-CH2CN H H H H
2.034 3-Cl, 5-NO2 3-CH2CN H H H H
2.035 3-Cl, 5-NH2 3-CH2CN H H H H
2.036 H (n=0) 3-CH2CN, 4-F H H H H
2.037 3-F 3-CH2CN, 4-F H H H H
2.038 3-Cl 3-CH2CN, 4-F H H H H
2.039 3-F, 5-F 3-CH2CN, 4-F H H H H
Cmp. Ri R2 Rl31 Rl32 R133 R134 no.
2.040 3-F, 5-C1 3-CH2CN, 4-F H H H H
2.041 5-CF3 3-CH2CN, 4-F H H H H
2.042 3-F, 5-CF3 3-CH2CN, 4-F H H H H
2.043 3-Cl, 5-CF3 3-CH2CN, 4-F H H H H
2.044 5-CN 3-CH2CN, 4-F H H H H
2.045 3-F, 5-CN 3-CH2CN, 4-F H H H H
2.046 3-OCH3 3-CH2CN, 4-F H H H H
2.047 3-OCH3, 5-F 3-CH2CN, 4-F H H H H
2.048 3-OCH3, 5-C1 3-CH2CN, 4-F H H H H
2.049 3-OCH3, 5-CF3 3-CH2CN, 4-F H H H H
2.050 3-OCH3, 5-CN 3-CH2CN, 4-F H H H H
2.051 5-NO2 3-CH2CN, 4-F H H H H
2.052 3-Cl, 5-NO2 3-CH2CN, 4-F H H H H
2.053 3-F 3-CH2CN, 6-F H H H H
2.054 3-F, 5-F 3-CH2CN, 6-F H H H H
2.055 3-F, 5-C1 3-CH2CN, 6-F H H H H
2.056 5-CF3 3-CH2CN, 6-F H H H H
2.057 3-F, 5-CF3 3-CH2CN, 6-F H H H H
2.058 5-CN 3-CH2CN, 6-F H H H H
2.059 3-OCH3 3-CH2CN, 6-F H H H H
2.060 3-OCH3, 5-F 3-CH2CN, 6-F H H H H
2.061 3-OCH3, 5-C1 3-CH2CN, 6-F H H H H
2.062 3-OCH3, 5-CF3 3-CH2CN, 6-F H H H H
2.063 3-OCH3, 5-CN 3-CH2CN, 6-F H H H H
2.064 3-F 3-CH2CN, 4-F, 6-F H H H H
2.065 3-F, 5-F 3-CH2CN, 4-F, 6-F H H H - H
2.066 3-F, 5-C1 3-CH2CN, 4-F, 6-F H H H H
2.067 5-CF3 3-CH2CN, 4-F, 6-F H H H H
2.068 3-F, 5-CF3 3-CH2CN, 4-F, 6-F H H H H
2.069 5-CN 3-CH2CN, 4-F, 6-F H H H H
_ .
Cmp. Ri R2 Rl31 Rl32 R133 R134 no.
2.070 3-OCH3 3-CH2CN, 4-F, 6-F H H H H
2.071 3-OCH3, 5-F 3-CH2CN, 4-F, 6-F H H H H
2.072 3-OCH3, 5-C1 3-CH2CN, 4-F, 6-F H H H H
2.073 3-OCTΪ3, 5-CF3 3-CH2CN, 4-F, 6-F H H H H
2.074 3-OCH3, 5-CN 3-CH2CN, 4-F, 6-F H H H H
2.075 3-F 3-CH2CN, 4-Cl, 6-F H H H H
2.076 3-F, 5-F . 3-CH2CN, 4-Cl, 6-F H H H H
2.077 3-F, 5-C1 3-CH2CN, 4-Cl, 6-F H H H H
2.078 5-CF3 3-CH2CN, 4-Cl, 6-F H H H H
2.079 3-F, 5-CF3 3-CH2CN, 4-Cl, 6-F H H H H
2.080 5-CN 3-CH2CN, 4-Cl, 6-F H H H H
2.081 3-OCH3 3-CH2CN, 4-Cl, 6-F H H H , H
2.082 3-OCH3, 5-F 3-CH2CN, 4-Cl, 6-F H Ή H H
2.083 3-OCH3, 5-C1 3-CH2CN, 4-Cl, 6-F H H H H
2.084 3-OCH3, 5-CF3 3-CH2CN, 4-Cl, 6-F H H H H
2.085 3-OCH3, 5-CN 3-CH2CN, 4-Cl, 6-F H H H H
2.086 3-F 3-CH(CH3)CN H H H H
2.087 3-F, 5-F 3-CH(CH3)CN H H H H
2.088 3-F, 5-C1 3-CH(CH3)CN H H H H
2.089 5-CF3 3-CH(CH3)CN H H H H
2.090 3-F, 5-CF3 3-CH(CH3)CN H H H H
2.091 5-CN 3-CH(CH3)CN H H H H
2.092 3-OCH3 3-CH(CH3)CN H H H H
2.093 3-OCH3, 5-F 3-CH(CH3)CN H H • H H
2.094 3-OCH3, 5-C1 3-CH(CH3)CN H H H H
2.095 3-OCH3, 5-CF3 3-CH(CH3)CN H H H H
2.096 3-OCH3, 5-CN 3-CH(CH3)CN H H H H
2.097 3-F 3-CHF2 H H H H
2.098 3-F, 5-F 3-CHF2 H H H H
2.099 3-F, 5-C1 3-CHF2 H H H H
Cmp. Ri R2 R131 Rl32 R133 R134 no.
2.100 5-CF3 3-CHF2 H H H H
2.101 3-F, 5-CF3 3-CHF2 H H H H
2.102 5-CN 3-CHF2 H H H H
2.103 3-OCH3 3-CHF2 H H H H
2.104 3-OCH3, 5-F 3-CHF2 H H H H
2.105 3-OCH3, 5-C1 3-CHF2 H H H H
2.106 3-OCH3, 5-CF3 3-CHF2 H H H H
2.107 3-OCH3, 5-CN 3-CHF2 H H H H
2.108 3-F, 5-F 3-CHF2, 4-F H H H H
2.109 5-CF3 3-CHF2, 4-F H H H H
2.110 3-F, 5-CF3 3-CHF2, 4-F H H H H
2.111 3-OCH3 3-CHF2, 4-F H H H H
2.112 3-OCH3, 5-C1 3-CHF2, 4-F H H H H
2.113 3-OCH3, 5-CF3 3-CHF2, 4-F H H H H
2.114 3-F 3-CH2CN H H =0
2.115 3-F, 5-F 3-CH2CN H H =0
2.116 3-F, 5-C1 3-CH2CN H H =0
2.117 5-CF3 3-CH2CN H H =0
2.118 3-F, 5-CF3 3-CH2CN H H =0
2.119 5-CN 3-CH2CN H H =0
2.120 3-OCH3 3-CH2CN H H =0
2.121 3-OCH3, 5-F 3-CH2CN H H =0
2.122 3-OCH3, 5-C1 3-CH2CN H H =0
2.123 3-OCH3, 5-CF3 3-CH2CN H H =0
2.124 3-OCH3, 5-CN 3-CH2CN H H =0
2.125 3-F 3-CHF2 H H =0
2.126 3-F, 5-F 3-CHF2 H H =O
2.127 3-F, 5-C1 3-CHF2 H H =O
2.128 5-CF3 3-CHF2 H H =O
2.129 3-F, 5-CF3 3-CHF2 H H =O
Cmp. Ri R2 Rl31 Rl32 R133 R134 no.
2.130 5-CN 3-CHF2 H H =0
2.131 3-OCH3 3-CHF2 H H =0
2.132 3-OCH3, 5-F 3-CHF2 H H =0
'2.133 3-OCH3, 5-C1 3-CHF2 H H =0
2.134 3-OCH3, 5-CF3 3-CHF2 H H =0
2.135 3-OCH3, 5-CN 3-CHF2 H H =0
2.136 3-F 3-CH2CN H H OH H
2.137 3-F, 5-F 3-CH2CN H H OH H
2.138 3-F, 5-C1 3-CH2CN H H OH H
2.139 5-CF3 3-CH2CN H H OH H
2.140 3-F, 5-CF3 3-CH2CN H H OH H
2.141 5-CN 3-CH2CN H H OH H
2.142 3-OCH3 3-CH2CN H H OH H
2.143 3-OCH3, 5-F 3-CH2CN H H OH H
2.144 3-OCH3, 5-C1 3-CH2CN H H OH H
2.145 3-OCH3, 5-CF3 3-CH2CN H H OH H
2.146 3-OCH3, 5-CN 3-CH2CN H H OH H
2.147 3-F 3-CH2CN H H F H
2.148 3-F, 5-F 3-CH2CN H H F H
2.149 3-F, 5-C1 3-CH2CN H H F H
2.150 5-CF3 3-CH2CN H H F H
2.151 3-F, 5-CF3 3-CH2CN H H F H
2.152 5-CN 3-CH2CN H H F H
2.153 3-OCH3 3-CH2CN H H F H
2.154 3-OCH3, 5-F 3-CH2CN H H F H
2.155 3-OCH3, 5-C1 . 3-CH2CN H H F H
2.156 3-OCH3, 5-CF3 3-CH2CN H H F H
2.157 3-OCH3, 5-CN 3-CH2CN H H F H
2.158 3-F 3-CH2CN H H F F
2.159 3-F, 5-F 3-CH2CN H H F F
Cmp. Ri R2 Rl31 Rl32 R133 Rl34 no. 2.160 3-F, 5-C1 3-CH2CN H H F F
2.161 5-CF3 3-CH2CN H H F F
2.162 3-F, 5-CF3 3-CH2CN H H F F
2.163 5-CN 3-CH2CN H H F F
2.164 3-OCH3 3-CH2CN H H F F
2.165 3-OCH3, 5-F 3-CH2CN H H F F
■2.166 3-OCH3, 5-C1 3-CH2CN H H . F F
2.167 3-OCH3, 5-CF3 3-CH2CN. H H F F
2.168 3-OCH3, 5-CN 3-CH2CN H H F F
2.169 3-F, 5-F 3-CH2CN H H OCH3 H
2.170 5-CF3 3-CH2CN H H OCH3 H
2.171 3-F, 5-CF3 3-CH2CN H H OCH3 H
2.172 3-OCH3 3-CH2CN H H OCH3 H
2.173 3-OCH3, 5-C1 3-CH2CN • H H OCH3 H
2.174 3-OCH3, 5-CF3 3-CH2CN H H OCH3 H
2.175 3-F 3-CH2CN H H CH3 H
2.176 3-F, 5-F . 3-CH2CN H H CH3 H
2.177 3-F, 5-C1 3-CH2CN H H CH3 H
2.178 5-CF3 3-CH2CN H H CH3 H
2.179 3-F, 5-CF3 3-CH2CN H H CH3 H
2.180 5-CN 3-CH2CN H H CH3 H
2.181 3-OCH3 3-CH2CN H H CH3 H
2.182 3-OCH3, 5-F 3-CH2CN H H CH3 H
2.183 3-OCH3, 5-C1 3-CH2CN • H H CH3 H
2.184 3-OCH3, 5-CF3 3-CH2CN H H CH3 H
2.185 3-OCH3, 5-CN 3-CH2CN H H . CH3 H
2.186 3-F 3-CH2CN H H CH3 CH3
2.187 3-F, 5-F 3-CH2CN H H CH3 CH3
2.188 3-F, 5-C1 3-CH2CN H H CH3 CH3
2.189 5-CF3 3-CH2CN H H CH3 CH3
Cmp. Ri R2 Rl31 Rl32 R133 R134 no.
2.190 3-F, 5-CF3 3-CH2CN H H CH3 CH3
2.191 5-CN 3-CH2CN H H CH3 CH3
2.192 3-OCH3 3-CH2CN H H CH3 CH3
2.193 3-OCH3, 5-F 3-CH2CN H H CH3 CH3
2.194 3-OCH3, 5-C1 3-CH2CN H H CH3 CH3
2.195 3-OCH3, 5-CF3 3-CH2CN H H CH3 CH3
2.196 3-OCH3, 5-CN 3-CH2CN H H CH3 CH3
2.197 3-F 3-CH2CN H H C2alkylene
2.198 3-F, 5-F 3-CH2CN H H C2alkylene
2.199 3-F, 5-C1 3-CH2CN H H C2alkylene
2.200 5-CF3 3-CH2CN H H C2alkylene
2.201 3-F, 5-CF3 3-CH2CN H H C2alkylene
2.202 5-CN 3-CH2CN H H C alkylene
2.203 3-OCH3 3-CH2CN H H C2alkylene
2.204 3-OCH3, 5-F 3-CH2CN H H C alkylene
2.205 3-OCH3, 5-C1 3-CH2CN H H C2alkylene
2.206 3-OCH3, 5-CF3 3-CH2CN H H C2alkylene
2.207 3-OCH3, 5-CN 3-CH2CN H H C2alkylene
2.208 3-F, 5-F 3-CHF2 H H OH H
2.209 5-CF3 3-CHF2 H H OH H
2.210 3-F, 5-CF3 3-CHF2 H H OH H
2.211 3-OCH3 3-CHF2 H H OH H
2.212 3-OCH3, 5-C1 3-CHF2 H H OH H
2.213 3-OCH3, 5-CF3 3-CHF2 H H OH H
2.214 3-F, 5-F 3-CH(CH3)CN H H OH H
2.215 5-CF3 3-CH(CH3)CN H H OH H
2.216 3-F, 5-CF3 3-CH(CH3)CN H H OH H
2.217 3-OCH3 3-CH(CH3)CN H H OH H
2.218 3-OCH3, 5-C1 3-CH(CH3)CN H H OH H
2.219 3-OCH
3, 5-CF
3 3-CH(CH
3)CN H H OH H
Cmp. Ri R
2 Rl31 Rl32 R133 Rl34 no. 2.250 3-OCH
3 3-CH(CH
3)CN H H F F
2.251 3-OCH3, 5-C1 3-CH(CH3)CN H H F F
2.252 3-OCH3, 5-CF3 3-CH(CH3)CN H H F F
2.253 5-CN 3-CH(CH3)CN H H F F
2.254 3-F, 5-F 3-CH2CN, 4-F H H F F
2.255 5-CF3 3-CH2CN, 4-F H H F F
2.256 3-F, 5-CF3 3-CH2CN, 4-F H H F F '
2.257 3-OCH3, 5-C1 3-CH2CN, 4-F H H F F
2.258 3-OCH3, 5-CF3 3-CH2CN, 4-F H H F F
2.259 3-F, 5-F 3-CHF2 H H CH3 F
2.260 5-CF3 3-CHF2 H H CH3 F
2.261 3-F, 5-CF3 3-CHF2 H H CH3 F
2.262 3-OCH3, 5-C1 3-CHF2 H H CH3 F
2.263 3-OCH3, 5-CF3 3-CHF2 H H CH3 F
2.264 3-F, 5-F 3-CH(CH3)CN H H CH3 F
2.265 5-CF3 3-CH(CH3)CN H H CH3 F
2.266 3-F, 5-CF3 3-CH(CH3)CN H H CH3 F
2.267 3-OCH3, 5-C1 3-CH(CH3)CN H H CH3 F
2.268 3-OCH3, 5-CF3 3-CH(CH3)CN H H CH3 F
2.269 3-F, 5-F 3-CH2CN, 4-F H H CH3 F
2.270 5-CF3 3-CH2CN, 4-F H H CH3 F
2.271 3-F, 5-CF3 3-CH2CN, 4-F H H CH3 F
2.272 3-OCH3, 5-C1 3-CH2CN, 4-F H ' H CH3 F
2.273 3-OCH3, 5-CF3 3-CH2CN, 4-F H H CH3 F
2.274 3-F, 5-F 3-CHF2 H H * CH3 CH3
2.275 5-CF3 3-CHF2 H H CH3 CH3
2.276 3-F, 5-CF3 3-CHF2 H H CH3 CH3
2.277 3-OCH3, 5-C1 3-CHF2 H H CH3 CH3
2.278 3-OCH3, 5-CF3 3-CHF2 H H CH3 CH3
2.279 3-F, 5-F 3-CH(CH3)CN H H CH3 CH3
Cmp. Ri R2 Rl31 Rl32 R133 R134 no.
2.280 5-CF3 3-CH(CH3)CN H H CH3 CH3
2.281 3-F, 5-CF3 3-CH(CH3)CN H H CH3 CH3
2.282 3-OCH3, 5-C1 3-CH(CH3)CN H H CH3 CH3
2.283 3-OCH3, 5-CF3 3-CH(CH3)CN H H CH3 CH3
2.284 3-F, 5-F 3-CH2CN, 4-F H H CH3 CH3
2.285 5-CF3 3-CH2CN, 4-F H H CH3 CH3
2.286 3-F, 5-CF3 3-CH2CN, 4-F H H CH3 CH3
2.287 3-OCH3, 5-C1 3-CH2CN, 4-F H H CH3 CH3
2.288 3-OCH3, 5-CF3 3-CH2CN, 4-F H H CH3 CH3
2.289 3-F, 5-F 3-CHF2 H H OCH3 H
2.290 5-CF3 3-CHF2 H H OCH3 H
2.291 3-F, 5-CF3 3-CHF2 H H OCH3 H
2.292 3-OCH3, 5-C1 3-CHF2 H H • OCH3 H
2.293 3-OCH3, 5-CF3 3-CHF2 H H OCH3 H
2.294 3-F, 5-F 3-CH(CH3)CN H H OCH3 H
2.295 5-CF3 3-CH(CH3)CN H H OCH3 H
2.296 3-F, 5-CF3 3-CH(CH3)CN H H OCH3 H
2.297 3-OCH3, 5-C1 3-CH(CH3)CN H H OCH3 H
2.298 3-OCH3, 5-CF3 3-CH(CH3)CN H H OCH3 H
2.299 3-F, 5-F 3-CH2CN, 4-F H H OCH3 H
2.300 5-CF3 3-CH2CN, 4-F H H OCH3 H
2.301 3-F, 5-CF3 3-CH2CN, 4-F H H OCH3 H
2.302 3-OCH3, 5-C1 3-CH2CN, 4-F H H OCH3 H
2.303 3-OCH3, 5-CF3 3-CH2CN, 4-F H H OCH3 H
2.304 3-F 3-CH2CN H CH3 H H
2.305 3-F, 5-F 3-CH2CN H CH3 H H
2.306 3-F, 5-C1 3-CH2CN H CH3 H H
2.307 5-CF3 3-CH2CN H CH3 H H
2.308 3-F, 5-CF3 3-CH2CN H CH3 H H
2.309 5-CN 3-CH2CN . H CH3 H H
Cmp. Ri R2 Rl31 Rl32 R133 R134 no. 2.310 3-OCH3 3-CH2CN H CH3 H H
2.311 3-OCH3, 5-F 3-CH2CN H CH3 H H
2.312 3-OCH3, 5-C1 3-CH2CN H CH3 H H
2.313 3-OCH3, 5-CF3 3-CH2CN H CH3 H H
2.314 3-OCH3, 5-CN 3-CH2CN H CH3 H H
2.315 3-F 3-CH2CN H CH3 CH3 H
2.316 3-F, 5-F 3-CH2CN H CH3 CH3 H
2.317 3-F, 5-C1 3-CH2CN H CH3 CH3 H
2.318 5-CF3 3-CH2CN H CH3 CH3 H
2.319 3-F, 5-CF3 3-CH2CN H CH3 CH3 H
2.320 5-CN 3-CH2CN H CH3 CH3 H
2.321 3-OCH3 3-CH2CN H CH3 CH3 H
2.322 3-OCH3, 5-F 3-CH2CN H CH3 CH3 H
2.323 3-OCH3, 5-C1 3-CH2CN H CH3 CH3 H
2.324 3-OCH3, 5-CF3 3-CH2CN H CH3 CH3 H
2.325 3-OCH3, 5-CN 3-CH2CN H CH3. CH3 H
2.326 3-F 3-CH2CN H CH3 CH3 CH3
2.327 3-F, 5-F 3-CH2CN H CH3 CH3 CH3
2.328 3-F, 5-C1 3-CH2CN H CH3 CH3 CH3
2.329 5-CF3 3-CH2CN H CH3 CH3 CH3
2.330 3-F, 5-CF3 3-CH2CN H CH3 CH3 CH3
2.331 5-CN 3-CH2CN H CH3 CH3 CH3
2.332 3-OCH3 3-CH2CN H CH3 CH3 CH3
2.333 3-OCH3, 5-F 3-CH2CN H CH3 CH3 CH3
2.334 3-OCH3, 5-C1 3-CH2CN H CH3 CH3 CH3
2.335 3-OCH3, 5-CF3 3-CH2CN H CH3 CH3 CH3
2.336 3-OCH3, 5-CN 3-CH2CN H CH3 CH3 CH3
2.337 3-F 3-CH2CN H CH3 F F
2.338 3-F, 5-F 3-CH2CN H CH3 F F
2.339 3-F, 5-C1 3-CH
2CN H CH
3 F F
Cmp. Ri R
2 Rl31 Rl3
2 R133 R134 . no.
2.370 3-OCH3, 5-CN 4-Cl H H F H
2.371 3-F, 5-F 3-NH2 H H H H
2.372 5-CF3 3-NH2 H H H H
2.373 3-F, 5-CF3 3-NH2 H H H H
2.374 3-OCH3, 5-C1 3-NH2 H H H H
2.375 3-OCH3, 5-CF3 3-NH2 H H H H
2.376 3-F, 5-F 3-NH-COCH3 H H H H
2.377 5-CF3 3-NH-COCH3 H H H H
2.378 3-F, 5-CF3 3-NH-COCH3 H H H H
2.379 3-OCH3, 5-C1 3-NH-COCH3 H H H H
2.380 3-OCH3, 5-CF3 3-NH-COCH3 H H H H
2.381 3-Cl, 5-C1 3-CH2CN H H H H
Table 3: Compounds of formula IaιbjQτ_:_
Cmp. R Ri R2 Rl31 Rl32 Rl41 Rl42 no.
3.001 CH3 H (n=0) H (m=0) H H H H
3.002 CH3 4-F H (m=0) H H H H
3.003 CH3 4-Cl H (m=0) H H H H
3.004 CH3 4-Br H (m=0) H H H H
3.005 CH3 4-1 H (m=0) H H H H
Cmp. R Ri R2 Rl31 Rl32 Rl41 Rl42 no.
3.006 CH3 4-CF3 H (m=0) H H H H
3.007 CH3 4-CN H (m=0) H H H H
3.008 CH3 4-CHO H (m=0) H H H H
3.009 CH3 4-CH=NOCH3 H (m=0) H H H H
3.010 CH3 4-CH3 H (m=0) H H H H
3.011 CH3 . 4-CH=CCl2 H (m=0) H H H H
3.012 CH3 H (n=0) 3-CH2CN H H H H
3.013 CH3 4-F 3-CH2CN H H H H
3.014 CH3 4-Cl 3-CH2CN H H H H
3.015 CH3 4-Br 3-CH2CN H H H H
3.016 CH3 4-1 3-CH2CN H H H H
3.017 CH3 4-CF3 3-CH2CN H H H H
3.018 CH3 4-CN 3-CH2CN H H H H
3.019 CH3 4-CHO 3-CH2CN H H H H
3.020 CH3 4-CH=NOCH3 3-CH2CN H H H H
3.021 CH3 4-CH3 3-CH2CN H H H H
3.022 CH3 4-CH=CCl2 3-CH2CN H H H H
3.023 CH3 H (n=0) 3-CH2CN, 4-F H H H H
3.024 CH3 4-F 3-CH2CN, 4-F H H H H
3.025 CH3 4-Br 3-CH2CN, 4-F H H H H
3.026 CH3 4-CN 3-CH2CN, 4-F H H H H
3.027 CH3 4-CF3 3-CH2CN, 4-F H H H H
3.028 CH3 4-CH=NOCH3 3-CH2CN, 4-F H H H H
3.029 CH3 H (n=0) 3-CH2CN, 6-F H H H H
3.030 CH3 4-F 3-CH2CN, 6-F H H H H
3.031 CH3 4-Br 3-CH2CN, 6-F H H H H
3.032 CH3 4-CN 3-CH2CN, 6-F H H H H
3.033 CH3 4-CF3 3-CH2CN, 6-F H H H H
3.034 CH3 4-CH=NOCH3 3-CH2CN, 6-F H H H H
3.035 CH3 H (n=0) 3-CH2CN, 4-F, 6-F H H H H
Cmp. R Ri R2 Rl31 Rl32 Rl41 Rl42 no. 3.036 CH3 4-F 3-CH2CN, 4-F, 6-F H H H H 3.037 CH3 4-Br 3-CH2CN, 4-F, 6-F H H H H 3.038 CH3 4-CN 3-CH2CN, 4-F, 6-F H H H H
3.039 CH3 4-CF3 3-CH2CN, 4-F, 6-F H H H H
3.040 CH3 4-CH=NOCH3 3-CH2CN, 4-F, 6-F H H H H
3.041 CH3 4-F 3-CH2CN, 4-Cl, 6-F H H H H
3.042 CH3 4-1 3-CH2CN, 4-Cl, 6-F H H H H
3.043 CH3 4-CN 3-CH2CN, 4-Cl, 6-F H H H H
3.044 CH3 4-CF3 3-CH2CN, 4-Cl, 6-F H H H H
3.045 CH3 4-CH=NOCH3 3-CH2CN, 4-Cl, 6-F H H H H
3.046 CH3 H (n=0) 3-CH(CH3)CN H H H H
3.047 CH3 4-F 3-CH(CH3)CN H H H H
3.048 CH3 4-Cl 3-CH(CH3)CN H H H H
3.049 CH3 4-Br 3-CH(CH3)CN H H H H
3.050 CH3 4-1 3-CH(CH3)CN H H H H
3.051 CH3 4-CF3 3-CH(CH3)CN H H H H
3.052 CH3 4-CN 3-CH(CH3)CN H H H H
3.053 CH3 4-CHO 3-CH(CH3)CN H H H H
3.054 CH3 4-CH=NOCH3 3-CH(CH3)CN H H H H
3.055 CH3 4-CH3 • 3-CH(CH3)CN H H H H
3.056 CH3 4-CH=CCl2 3-CH(CH3)CN H H H H
3.057 CH3 H (n=0) 3-CHF2 H H H H
3.058 CH3 4-F 3-CHF2 H H H H
3.059 CH3 4-Cl 3-CHF2 H H H H
3.060 CH3 4-Br 3-CHF2 H H H H
3.061 CH3 4-1 3-CHF2 H H H H
3.062 CH3 4-CF3 3-CHF2 H H H H
3.063 CH3 4-CN 3-CHF2 H H H H
3.064 CH3 4-CHO 3-CHF2 H H H H
3.065 CH
3. 4-CH=NOCH
3 3-CHF2 H H H H
Cmp. R Ri R
2 R131 Rl32 Rl41 Rl42 no.
3.096 CH3 4-F 3-CH2CN H H F H
3.097 CH3 4-Br 3-CH2CN H H F H
3.098 CH3 4-CH3 3-CH2CN H H F H
3.099 CH3 4-CN 3-CH2CN H H F H
3.100 CH3 4-CF3 3-CH2CN H H F H
3.101 CH3 4-CH=NOCH3 3-CH2CN H H F H
3.102 CH3 4-CN 3-CH2CN H H F H
3.103 CH3 H (n=0) 3-CH2CN H H Cl H
3.104 CH3 4-F 3-CH2CN H H Cl H
3.105 CH3 4-Br 3-CH2CN H H Cl H
3.106 CH3 4-CH3 3-CH2CN H H Cl H
3.107 CH3 4-CN 3-CH2CN H H Cl H
3.108 CH3 4-CF3 3-CH2CN H H Cl H
3.109 CH3 4-CH=NOCH3 3-CH2CN H H Cl H
3.110 CH3 H (n=0) 3-CH2CN , H H OCH3 H
3.111 CH3 4-F 3-CH2CN H H OCH3 H
3.112 CH3 4-Br 3-CH2CN H H OCH3 H
3.113 CH3 4-CH3 3-CH2CN H H OCH3 H
3.114 CH3 4-CN 3-CH2CN H H OCH3 H
3.115 CH3 4-CF3 3-CH2CN H H OCH3 H
3.116 CH3 4-CH=NOCH3 3-CH2CN H H OCH3 H
3.117 CH3 H (n=0) 3-CH2CN H H CH3 H
3.118 CH3 4-F 3-CH2CN H H CH3 H
3.119 CH3 4-Br 3-CH2CN H H CH3 H
3.120 CH3 4-CH3 3-CH2CN H H CH3 H
3.121 CH3 4-CN 3-CH2CN H H CH3 H
3.122 CH3 4-CF3 3-CH2CN H H CH3 H
3.123 CH3 4-CH=NOCH3 3-CH2CN H H CH3 H
3.124 CH3 H (n=0) 3-CH2CN H H CH3 CH3
3.125 CH3 4-F 3-CH2CN H H CH3 CH3
Cmp. R Ri R2 R131 Rl32 Rl41 Rl42 no.
3.126 CH3 4-Br 3-CH2CN H H CH3 CH3
3.127 CH3 4-CH3 3-CH2CN H H CH3 CH3
3.128 CH3 4-CN 3-CH2CN H H CH3 CH3
3.129 CH3 4-CF3 3-CH2CN H H CH3 CH3
3.130 CH3 4-CH=NOCH3 3-CH2CN H H CH3 CH3
3.131 CH3 H (n=0) 3-CH2CN H H C2alkylene
3.132 CH3 4-F 3-CH2CN H H C2alkylene
3.133 CH3 4-Br 3-CH2CN H H C2alkylene
3.134 CH3 4-CH3 3-CH2CN H H C2alkylene
3.135 CH3 4-CN 3-CH2CN H H C2alkylene
3.136 CH3 4-CF3 3-CH2CN H H C2alkylene
3.137 CH3 4-CH=NOCH3 3-CH2CN H H C alkylene
3.138 CH3 H (n=0) 3-CHF2 H H OH H
3.139 CH3 4-F 3-CHF2 H H OH H
3.140 CH3 4-CN 3-CHF2 H H OH H
3.141 CH3 H (n=0) 3-CH(CH3)CN H H OH H
3.142 CH3 4-F 3-CH(CH3)CN H H OH H
3.143 CH3 4-CN 3-CH(CH3)CN H H OH H
3.144 CH3 H (n=0) 3-CH2CN, 4-F H H OH H
3.145 CH3 4-F 3-CH2CN, 4-F H H OH H
3.146 CH3 4-CN 3-CH2CN, 4-F H H OH H
3.147 CH3 H (n=0) 3-CHF2 H H F H
3.148 CH3 4-F 3-CHF2 H H F H
3.149 CH3 4-CN 3-CHF2 H H F H
3.150 CH3 H (n=0) 3-CH(CH3)CN H H F H
3.151 CH3 4-F 3-CH(CH3)CN H H F Η
3.152 CH3 4-CN 3-CH(CH3)CN H H F H
3.153 CH3 H (n=0) 3-CH2CN, 4-F H H F H
3.154 CH3 4-F 3-CH2CN, 4-F H H F H
3.155 CH3 4-CN 3-CH2CN, 4-F H H F H
Cmp. R Ri R2 Rl31 R132 Rl41 Rl42 no.
3.156 CH3 H (n=0) 3-CHF2 H H Cl H
3.157 CH3 4-F 3-CHF2 H H Cl H
3.158 CH3 4-CN 3-CHF2 H H Cl H
3.159 CH3 H (n=0) 3-CH(CH3)CN H H Cl H
3.160 CH3 4-F 3-CH(CH3)CN H H Cl H
3.161 CH3 4-CN 3-CH(CH3)CN H H Cl H
3.162 CH3 4-CH=NOCH3 3-CH(CH3)CN H H Cl H
3.163 CH3 H (n=0) 3-CH2CN, 4-F H H Cl H
3.164 CH3 4-F 3-CH2CN, 4-F H H Cl H
3.165 CH3 4-CN 3-CH2CN, 4-F H H Cl H
3.166 CH3 H (n=0) 3-CHF2 H H CH3 OH
3.167 CH3 4-F 3-CHF2 H H CH3 OH
3.168 CH3 4-CN 3-CHF2 H H CH3 OH
3.169 CH3 H (n=0) 3-CH(CH3)CN H H CH3 OH
3.170 CH3 4-F 3-CH(CH3)CN H H CH3 OH
3.171 CH3 4-CN 3-CH(CH3)CN H H CH3 OH
3.172 CH3 4-CH=NOCH3 3-CH(CH3)CN H H CH3 OH
3.173 CH3 H (n=0) 3-CH2CN, 4-F H H CH3 OH
3.174 CH3 4-F 3-CH2CN, 4-F H H CH3 OH
3.175 CH3 . 4-CN 3-CH2CN, 4-F H H CH3 OH
3.176 CH3 H (n=0) 3-CHF2 H H CH3 CH3
3.177 CH3 4-F 3-CHF2 H H CH3 CH3
3.178 CH3 4-CN 3-CHF2 H H CH3 CH3
3.179 CH3 H (n=0) 3-CH(CH3)CN H H CH3 CH3
3.180 CH3 4-F 3-CH(CH3)CN H H CH3 CH3
3.181 CH3 4-CN 3-CH(CH3)CN H H CH3 CH3
3.182 CH3 H (n=0) 3-CH2CN, 4-F H H CH3 CH3
3.183 CH3 4-F 3-CH2CN, 4-F H H CH3 CH3
3.184 CH3 4-CN 3-CH2CN, 4-F H H CH3 CH3
3.185 CH3 H (n=0) 3-CHF2 H H OCH3 H
Cmp. R Ri R2 Rl31 Rl32 Rl41 Rl42 no.
3.186 CH3 4-F 3-CHF2 H H ■ OCH3 H
3.187 CH3 4-CN 3-CHF2 H H OCH3 H
3.188 CH3 H (n=0) 3-CH(CH3)CN H H OCH3 H
3.189 CH3 4-F 3-CH(CH3)CN H H OCH3 H
3.190 CH3 4-CN 3-CH(CH3)CN H H OCH3 H
3.191 CH3 H (n=0) 3-CH2CN, 4-F H H OCH3 H
3.192 CH3 4-F 3-CH2CN, 4-F H H OCH3 H
3.193 CH3 4-CN 3-CH2CN, 4-F H H OCH3 H
3.194 CH3 H (n=0) 3-CH2CN H CH3 H H
3.195 CH3 4-F 3-CH2CN H CH3 H H
3.196 CH3 4-Br 3-CH2CN H CH3 H H
3.197 CH3 4-CH3 3-CH2CN H CH3 H H
3.198 CH3 4-CN 3-CH2CN H CH3 H H
3.199 CH3 4-CF3 3-CH2CN H CH3 H H
3.200 CH3 4-CH=NOCH3 3-CH2CN H CH3 H H
3.201 CH3 H (n=0) 3-CH2CN H CH3 CH3 H
3.202 CH3 4-F 3-CH2CN H CH3 CH3 H
3.203 CH3 4-Br 3-CH2CN H CH3 CH3 H
3.204 CH3 4-CH3 3-CH2CN H CH3 CH3 H
3.205 CH3 4-CN 3-CH2CN H CH3 CH3 H
3.206 CH3 4-CF3 3-CH2CN H CH3 CH3 H
3.207 CH3 4-CH=NOCH3 3-CH2CN H CH3 CH3 H
3.208 CH3 H (n=0) 3-CH CN H CH3 CH3 CH3
3.209 CH3 4-F 3-CH2CN H CH3 CH3 CH3
3.210 CH3 4-Br 3-CH2CN H CH3 CH3 CH3
3.211 CH3 4-CH3 3-CH2CN H CH3 CH3 CH3
3.212 CH3 4-CN 3-CH2CN H CH3 CH3 CH3
3.213 CH3 4-CF3 3-CH2CN H CH3 CH3 CH3
3.214 CH3 4-CH=NOCH3 3-CH2CN H CH3 CH3 CH3
3.215 CH
3 H (n=0) 3-CH2CN H CH
3 F H
Table A: Compounds prepared, from Tables 1-3 above
Example Bl: Herbicidal action prior to emergence of the plants (pre-emergence action Monocotyledonous and dicotyledonous test plants are sown in standard soil in pots. Immediately after sowing, the test compounds, in the form of an aqueous suspension (prepared from a wettable powder (Example F3, b) according to WO 97/34485) or in the form of an emulsion (prepared from an emulsifiable concentrate (Example FI, c) according to WO 97/34485), are applied by spraying, in an optimum concentration (500 litres of water per ha). The test plants are then grown in a greenhouse under optimum conditions. After a test duration of 4 weeks, the test is evaluated in accordance with a scale of eleven ratings (10 = total damage, 0 = no action). Ratings of from 7 to 10 (especially from 8 to 10) indicate good to very good herbicidal action.
In this test, the compounds of formula I exhibit strong herbicidal action. The same results are obtained when the compounds of formula I are formulated analogously to the other Examples of WO 97/34485.
Example B2: Post-emergence herbicidal action
Monocotyledonous and dicotyledonous test plants are sown in standard soil in pots. When the test plants are at the 2- to 3 -leaf stage, the test compounds, in the form of an aqueous suspension (prepared from a wettable powder (Example F3, b) according to WO 97/34485) or in the form of an emulsion (prepared from an emulsifiable concentrate (Example FI, c) according to WO 97/34485), are applied by spraying, in an optimum concentration (500 litres of water per ha). The test plants are then grown on in a greenhouse under optimum conditions.
After a test duration of 2 to 3 weeks, the test is evaluated in accordance with a scale of eleven ratings (10 = total damage, 0 = no action). Ratings of from 7 to 10 (especially from 8 to 10) indicate good to very good herbicidal action.
Test plants: Sida, Abutilon, Amaranthus, Chenopodium, Stellaria, Panicum, Euphorbia, Galium, Veronica, Kochia.
Table B2: Concentration: 1000 g of active substance per ha
Table B2a: Concentration: 1000 g of active substance per ha
Table B2b: Concentration: 1000 g of active substance per ha
The same results are obtained when the compounds of formula I are formulated analogously to the other Examples of WO 97/34485.
The compounds of formula I according to the invention may also be used in admixture with known herbicides as co-herbicides for controlling weeds, for example as ready- for- use formulations or in the form of a 'tank-mix'. As mixing partners for the compounds of formula I, there are suitable, for example, the following co-herbicides: compound of formula I + triasulfuron; compound of formula I + prosulfuron; compound of formula I + clodinafop; compound of formula I + terbutryn; compound of formula I + dicamba; compound of formula I + cloquintocet-mexyl; compound of formula I + fenoxaprop-P- ethyl; compound of formula I + diclo fop-methyl; compound of formula I + tralkoxydim; compound of formula I + amidosulfuron; compound of formula I + chlorsulfuron; compound of formula I + ethoxysulfuron; compound of formula I + flupyrsulfuron; compound of formula I + flupyrsulfuron-methyl-sodium; compound of formula I + metsulfuron-methyl; compound of formula I + sulfosulfuron; compound of formula I + thifensulfuron-methyl; compound of formula I + tribenuron-methyl; compound of formula I + imazamethabenz-methyl; compound of formula I + flucarbazone; compound of formula I + iodosulfuron; compound of formula I + florasulam; compound of formula I + flumetsulam; compound of formula I + metosulam; compound of formula I + chlorotoluron; compound of formula I + isoproturon; compound of formula I + methabenzthiazuron; compound of formula I + bromoxynil; compound of formula I + ioxynil; compound of formula I + pyridate; compound of formula I + bifenox; compound of formula I + fluoroglycofen-ethyl; compound of formula I + carfentrazone; compound of formula I + JV485 (MON48500); compound of formula I + diflufenican; compound of formula I + flurtamone; compound of formula I + glyphosate; compound of formula I + sulfosate; compound of formula I + glufosinate; compound of formula I + S-glufosinate; compound of formula I + bialaphos; compound of formula I + ethalfluralin; compound of formula I + pendimethalin; compound of formula I + trifluralin; compound of formula I + fluthiamid; compound of formula I + isoxaben; compound of formula I + prosulfocarb; compound of formula I + triallate; compound of formula I + 2,4-D; compound of formula I + 2,4-DB; compound of formula I + dichlorprop (2,4-DP); compound of formula I + MCPA; compound of formula I + MCPB; compound of formula I-+ mecoprop (MCPP); compound of formula I + mecoprop-P; compound of formula I + clopyralid; compound of formula I + fluroxypyr; compound of formula I + quinmerac; compound of formula I + benazolin-ethyl; compound of formula I + difenzoquat; compound of formula I + cyhalofop-butyl; compound of formula I + cinosulfuron; compound of formula I +
fenclorim; compound of formula I + butafenacil; compound of formula I + clodinafop- propargyl; compound of formula I + metolachlor; compound of formula I + S-metolachlor; compound of formula I + bensulfuron; compound of formula I + imazosulfuron; compound of formula I + pyrazosulfuron; compound of formula I + metsulfuron; compound of formula I + azimsulfuron; compound of formula I + ACO 14; compound of formula I + esprocarb; compound of formula I + mefenacet; compound of formula I + molinate; compound of formula I + propanil; compound of formula I + pyrazolate; compound of formula I + fenoxaprop-ethyl; compound of formula I + bispyribac; compound of formula I + bispyribac-sodium; compound of formula I + pyriminobac-methyl; compound of formula I + cafenstrole; compound of formula I + MY-100; compound of formula I + dymron; compound of formula I + NB061; compound of formula I + MK243; compound of formula I + HW-52; compound of formula I + oxadiargyl; compound of formula I + halosulfuron-methyl; compound of formula I + clomazone; compound of formula I + oxadiazon; compound of formula I + SAN 1315; compound of formula I + mefenpyr; compound of formula I + chlormequat chloride; compound of formula I + clofencet; compound of formula I + cyclanilide; compound of formula I + ethephon; compound of formula I + flurprimidol; compound of formula I + gibberellic acid; compound of formula I + inabenfide; compound of formula I + maleic, acid hydrazide; compound of formula I + mefluidide; compound of formula I + mepiquat chloride; compound of formula I + paclobutrazol; compound of formula I + prohexadione calcium; compound of formula I + uniconazole; compound of formula I + thidiazuron; compound of formula I + azimsulfuron; compound of formula I + cyclosulfamuron; compound of formula I + fentrazamide; compound of formula I + flazasulfuron; compound of formula I + fluazolate; compound of formula I + flufenacet; compound of formula I + indanofan; compound of formula I + benfuresate; compound of formula I + bentazone; compound of formula I + bromobutide; compound of formula I + dichlorprop-P; compound of formula I + dithiopyr; compound of formula I + ethametsulfuron; compound of formula I + flamprop-M; compound of formula I + methyldymron; compound of formula I + quinclorac; compound of formula I + thiazopyr; compound of formula I + paraquat, and also esters and salts of those mixing partners of the compound of formula I, which are mentioned, for example, in 'The Pesticide Manual', Eleventh Edition, 1997, BCPC.